Citations

Citations to this article as recorded by  

• Challenges in defining MASLD in lean individuals: the impact of the Fatty Liver Index on phenotypic characterisation
  Sherlot Juan Song, Yiwei Liu, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip
  Gut.2026; : gutjnl-2026-338216.     CrossRef
• Beyond BMI: Reassessing the Prevalence of Obesity in Patients With MASLD Under the Lancet Commission Diagnostic Criteria
  Ru‐Tao Lin, Ren‐Qiang Zeng, Xu‐Ting Shen, Qin‐Mei Sun, Xin Xin, Jia‐Mei Chen, Yi‐Yang Hu, Qin Feng
  Diabetes, Obesity and Metabolism.2026;[Epub]     CrossRef
• Metabolic Dysfunction-Associated Steatotic Liver Disease and Incretin Receptor Agonists: A Metabolic Approach to Halting Liver Disease Progression
  Ludovico Abenavoli, Anna Giulia Loricchio, Ivo Lopez, Domenico Morano, Abdulrahman Ismaiel, Dan Lucian Dumitrascu, Francesco Luzza
  Medicina.2026; 62(5): 986.     CrossRef
• Estimated Body Fat Percentage and Triglyceride‐Glucose Index for Identifying MASLD in Lean Asian Adults: A Cross‐Sectional Analysis
  Xiang‐Ran Kong, Ya‐Li Chen, Rui Li, Lu‐Xiang Shang, Sha Sha
  The Kaohsiung Journal of Medical Sciences.2026;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Advancing metabolic risk profiling in chronic hepatitis B: Reply to correspondence on “Metabolic health in antiviral era of chronic hepatitis B”
  Shang-Chin Huang, Jia-Horng Kao
  Clinical and Molecular Hepatology.2026; 32(1): e117.     CrossRef
• Correspondence to editorial 1 on “Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues”
  Rui Huang, Mindie H. Nguyen
  Clinical and Molecular Hepatology.2026; 32(1): e83.     CrossRef
• Steatosis paradox: Unraveling pathways of suppressive effect of hepatic steatosis on hepatitis B virus
  Shang-Chin Huang, Jia-Horng Kao
  Biomedical Journal.2026; 49(3): 100969.     CrossRef
• The Chronic Hepatitis B and Metabolic Dysfunction-Associated Steatotic Liver Disease Paradox: Friend or Foe?
  Shang-Chin Huang, Tai-Chung Tseng
  Gut and Liver.2026; 20(3): 350.     CrossRef
• Insulin Resistance and Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients Under Antiviral Therapy
  Dong Hyun Sinn, Kyung-Ah Kim, Jung Il Lee, Geum-Youn Gwak
  Journal of Korean Medical Science.2026;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Association of Circadian Rhythms With the Risk of Chronic Liver Disease: Findings From a Large Prospective Study
  Rong Yang, Can Shen, Yu Jia, Yi Yao, Yiheng Zhou, Yu Cheng, Yonglang Cheng, Rui Zeng, Zhi Wan, Qian Zhao, Dongze Li, Xiaoyang Liao
  Clinical and Translational Gastroenterology.2026; 17(1): e00949.     CrossRef
• High-protein diets and metabolic dysfunction-associated steatotic liver disease: A double-edged sword in liver health
  Hong-Yuan Yin, Qian-Hui You, Wei-Jie Zhang, Guang Ji, Yan-Qi Dang
  World Journal of Gastroenterology.2026;[Epub]     CrossRef
• Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models
  Jack Leslie, Kishore A. Krishnamurthy, Indresh K. Gopalsamy, Patricia Inacio, Meritxell Huch, Suchira Gallage, Fiona Oakley, Michele Vacca
  Nature Reviews Gastroenterology & Hepatology.2026; 23(4): 286.     CrossRef
• 1-O-acetylbritannilactone alleviates high-fat diet-induced fatty liver by covalently targeting NLRP3
  Tianyang Jin, Yanni Zhao, Tingxin Xu, Yi Fang, Yaqian Cui, Wenqi Liu, Yongqiang Xiong, Jiaxi Ye, Wu Luo, Bo Hong, Guang Liang, Xiang Hu, Lijiang Huang, Yi Wang
  International Immunopharmacology.2026; 174: 116351.     CrossRef
• Competing Cardiometabolic Pathways of Obesity and Metabolic Dysfunction–Associated Steatotic Liver Disease
  Masashi Hirooka, Teruki Miyake, Ryo Yano, Yoshiko Nakamura, Yuki Okazaki, Toyoki Shimamoto, Atsushi Yukimoto, Yasunori Yamamoto, Takao Watanabe, Osamu Yoshida, Kana Hirooka, Yoshio Tokumoto, Masanori Abe, Takeru Iwata, Yoichi Hiasa
  Gastro Hep Advances.2026; 5(4): 100882.     CrossRef
• Using an integrative multi-omics and in vitro approach to investigate the role of tris(2-butoxyethyl) phosphate in promoting hepatic steatosis
  Gang Zhou, Xihan Gu, Xinyao Zhou, Shuai Chen, Hanyang Liu, Jing Wang
  BMJ Open Gastroenterology.2026; 13(1): e002123.     CrossRef
• Lipid metabolism-MAFLD crosstalk: mechanisms and therapy
  Bojia Li, Shengai Piao, Yin Fu, Qiang Fu, Peiyao Qin, Weitai Kong, Yidi Ma, Zhe Zhang, Xue Fang, Xiaoyang Hu
  Frontiers in Endocrinology.2026;[Epub]     CrossRef
• Current status survey and risk factor analysis of metabolic dysfunction-associated steatotic liver disease among adolescents in Hainan Province
  Shuo Zhou, Daya Zhang, Runyu Chen, Yan-ting Lv, Da Li, Xianfeng Huang, Fengjiao Mao, Shimei Huang, Shiju Chen, Chen Chen, Ying Mo, Yiping Du, Yuliang Huang, Fan Zeng, Qicen Yao, Feihu Bai
  Scientific Reports.2026;[Epub]     CrossRef
• Selenium Protects Against Cadmium-Induced Hepatotoxicity via Regulation of Lipid Metabolism and Inflammatory Pathways
  Zilong Wu, Xinyi Chen, Xiaoying Pan, Kai Luo, Zixiong Zhang, Changyu Zhou, Haibo Wang, Chuying Huang
  Frontiers in Bioscience-Landmark.2026;[Epub]     CrossRef
• Biomarkers for early identification of metabolic dysfunction-associated steatotic liver disease (MASLD): a narrative review
  Aleksandra Klisic, Ratko Tomašević, Slavko Djuraskovic, Filiz Mercantepe, Ana Ninic
  Archives of Medical Science.2026;[Epub]     CrossRef
• Contemporary epidemiology of metabolic dysfunction-associated steatotic liver disease
  Do Han Kim, Donghyun Ko, Aijaz Ahmed, Donghee Kim
  Expert Review of Gastroenterology & Hepatology.2026; : 1.     CrossRef
• PNPLA3 is one of the bridges between TM6SF2 E167K variant and MASLD: Correspondence to editorial on “TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD”
  Baokai Sun, Likun Zhuang
  Clinical and Molecular Hepatology.2025; 31(1): e67.     CrossRef
• TM6SF2 and PNPLA3: A potential dynamic duo?: Editorial on “TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD”
  Andrea Caddeo, Rosellina M. Mancina
  Clinical and Molecular Hepatology.2025; 31(1): 293.     CrossRef
• Causal roles of immune cells and metabolites in chronic pancreatitis: a mendelian randomization study
  Chao Zhang, Tao Yang, Yuan Yu, Qian Jia, Wan-Meng Xiao, Sha Liu, Ze-Hui Yu, Cheng-Li Wen, Yan Wei, Hao Li, Mu-Han Lü
  Hereditas.2025;[Epub]     CrossRef
• Effects of polyphenols on non-alcoholic fatty liver disease: a case study of resveratrol
  Ying Zhao, Jiali Ren, Weisan Chen, Xinchen Gao, Hongjian Yu, Xiankuan Li, Yanchao Zheng, Jinlong Yang
  Food & Function.2025; 16(8): 2926.     CrossRef
• Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease
  Mohammad Shafi Kuchay, Narendra Singh Choudhary, Bruno Ramos-Molina
  American Journal of Physiology-Cell Physiology.2025; 328(5): C1637.     CrossRef
• Beyond obesity: lean metabolic dysfunction-associated steatohepatitis from unveiling molecular pathogenesis to therapeutic advancement
  Indrajit Bhattacharya, Deep Kumar Maity, Amit Kumar, Sampriti Sarkar, Teeshyo Bhattacharya, Amrita Sahu, Remya Sreedhar, Somasundaram Arumugam
  Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(10): 13647.     CrossRef
• Liver disease trends in the Asia-Pacific region for the next 50 years
  Shuichiro Shiina, Javkhlan Maikhuu, Qing Deng, Terguunbileg Batsaikhan, Lariza Marie Canseco, Maki Tobari, Hitoshi Maruyama, Hiroaki Nagamatsu, Diana Alcantara-Payawal, Rino Gani, Yi-Hsiang Huang, Tawesak Tanwandee, Giovanni Galati, Yoon Jun Kim
  Clinical and Molecular Hepatology.2025; 31(3): 671.     CrossRef

Citations

Citations to this article as recorded by  

• The impact of hepatic steatosis on epicardial adipose tissue in obese individuals
  Gül Trabzon, Fatma Öztürk Keleş, Osman Fırat Çalışkan, Şükrü Güngör, Nuriye Yarar, Ufuk Utku Güllü
  Journal of Pediatric Endocrinology and Metabolism.2026; 39(1): 46.     CrossRef
• Metabolic dysfunction-associated steatotic liver disease and risk of four intrahepatic and extrahepatic diseases
  Yiyuan Xiao, Sihua Xu, Wenyan Hu, Jiapeng Huang, Deke Jiang, Rong Na, Zhaoqing Yin, Jingjing Zhang, Haitao Chen
  Annals of Hepatology.2025; 30(1): 101750.     CrossRef
• Bioinformatic analysis of molecular expression patterns during the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD)
  Yuanfeng Lan, Ran Song, Duiping Feng, Junqi He
  Scientific Reports.2025;[Epub]     CrossRef
• Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma
  Toru Nakamura, Atsutaka Masuda, Dan Nakano, Keisuke Amano, Tomoya Sano, Masahito Nakano, Takumi Kawaguchi
  Cells.2025; 14(6): 428.     CrossRef
• C-C motif chemokines ligand 7 contributes to metabolic dysfunction-associated steatotic liver disease by enabling redox-sensitive induction of hypermethylated in cancer 1
  Xinyue Sun, Jinge Wu, Huiqian Lv, Ben Wang, Xuelian Chen, Wenjing Ren, Xiulian Miao, Yan Guo, Xiaocen Kong, Huihui Xu, Zeqing Bao, Yong Xu, Zilong Li
  Metabolism.2025; 168: 156242.     CrossRef
• Phocaeicola dorei ameliorates progression of steatotic liver disease by regulating bile acid, lipid, inflammation and proliferation
  Jieun Choi, Ye Rin Choi, Min Kyo Jeong, Hyun Ho Song, Jeong Seok Yu, Seol Hui Song, Jeong Ha Park, Min Ju Kim, Hyunjoon Park, Young Lim Ham, Sang Hak Han, Dong Joon Kim, Do Yup Lee, Ki Tae Suk
  Gut Microbes.2025;[Epub]     CrossRef
• The effects of next generation probiotics on metabolic dysfunction-associated steatotic liver disease: a parallel, double-blind, randomized, placebo-controlled trial
  Sung-Min Won, Hyunchae Joung, In Gyu Park, Sang Hak Han, Young Lim Ham, Ji Sook Han, Yoojin Kwon, Dong Joon Kim, Ki Tae Suk
  Journal of Translational Medicine.2025;[Epub]     CrossRef
• Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation
  Byeong Hyun Min, Shivani Devi, Goo Hyun Kwon, Haripriya Gupta, Jin-Ju Jeong, Satya Priya Sharma, Sung-Min Won, Ki-Kwang Oh, Sang Jun Yoon, Hee Jin Park, Jung A Eom, Min Kyo Jeong, Ji Ye Hyun, Nattan Stalin, Tae-Sik Park, Jieun Choi, Do Yup Lee, Sang Hak H
  Gut Microbes.2024;[Epub]     CrossRef
• Association of metabolic dysfunction‐associated steatotic liver disease with erosive esophagitis development: a longitudinal observational study
  Masahiro Sogabe, Toshiya Okahisa, Miwako Kagawa, Motoko Sei, Hiroyuki Ueda, Reiko Yokoyama, Kaizo Kagemoto, Hironori Tanaka, Yoshifumi Kida, Fumika Nakamura, Tetsu Tomonari, Koichi Okamoto, Yutaka Kawano, Hiroshi Miyamoto, Yasushi Sato, Masahiko Nakasono,
  Journal of Gastroenterology and Hepatology.2024; 39(6): 1107.     CrossRef
• Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019
  Pojsakorn Danpanichkul, Kanokphong Suparan, Priyata Dutta, Chuthathip Kaeosri, Banthoon Sukphutanan, Yanfang Pang, Narathorn Kulthamrongsri, Methasit Jaisa-aad, Cheng Han Ng, Margaret Teng, Masahito Nakano, Asahiro Morishita, Naim Alkhouri, Ju Dong Yang,
  Metabolism.2024; 158: 155958.     CrossRef
• Gut microbiota-based machine-learning signature for the diagnosis of alcohol-associated and metabolic dysfunction-associated steatotic liver disease
  In-gyu Park, Sang Jun Yoon, Sung-min Won, Ki-Kwang Oh, Ji Ye Hyun, Ki Tae Suk, Unjoo Lee
  Scientific Reports.2024;[Epub]     CrossRef
• Are transmembrane 6 superfamily member 2 gene polymorphisms associated with steatohepatitis after pancreaticoduodenectomy?
  Tomotaka Mori, Eisuke Ozawa, Ryu Sasaki, Akane Shimakura, Kosuke Takahashi, Yoko Kido, Yasuko Kanda, Satoshi Matsuo, Kazuaki Tajima, Asami Beppu, Yasuhiko Nakao, Masanori Fukushima, Masafumi Haraguchi, Satoshi Miuma, Hisamitsu Miyaaki, Tomohiko Adachi, Su
  JGH Open.2024;[Epub]     CrossRef
• Association between nonalcholic fatty liver disease and pancreatic cancer: Epidemiology, mechanisms, and antidiabetic medication
  Takahiko Sakaue, Hiroya Terabe, Hidetoshi Takedatsu, Takumi Kawaguchi
  Hepatology Research.2024; 54(8): 729.     CrossRef
• Usefulness of health checkup‐based indices in identifying metabolic dysfunction‐associated steatotic liver disease
  Takao Miwa, Satoko Tajirika, Nanako Imamura, Miho Adachi, Ryo Horita, Tatsunori Hanai, Cheng Han Ng, Mohammad Shadab Siddiqui, Taku Fukao, Masahito Shimizu, Mayumi Yamamoto
  JGH Open.2024;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• FIB‐4 Serves as a Referral Index for Coronary Artery Calcification in Patients With MASLD
  Ya‐Chin Huang, Chih‐Wen Wang, Jiun‐Chi Huang, Po‐Cheng Liang, Ming‐Lun Yeh, Yi‐Yu Chen, Yi‐Hung Lin, Tyng‐Yuan Jang, Yu‐Ju Wei, Ming‐Yen Hsieh, Chao‐Kuan Huang, Hsu‐Han Chien, Chia‐Jen Wu, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang, Chia‐I Lin, Chung‐Fen
  Journal of Gastroenterology and Hepatology.2026; 41(1): 332.     CrossRef
• Targeting mTOR with vistusertib attenuates metabolic steatohepatitis and prevents HCC development
  Nidhi Sharma, Suriya Panneerselvam, Yogesh Chandra, Sai Balaji Andugulapati
  Inflammation Research.2026;[Epub]     CrossRef
• Cardiovascular Risk From Metabolic Dysfunction-Associated Steatotic Liver Disease, Cardiometabolic Risk Factor Count, and Their Longitudinal Changes: A Nationwide Cohort Study
  Hyeok-Hee Lee, Han Ah Lee, Eun-Jin Kim, Hwi Young Kim, Hyeon Chang Kim, Sang Hoon Ahn, Hokyou Lee, Seung Up Kim
  American Journal of Gastroenterology.2025; 120(10): 2321.     CrossRef
• Non-Invasive Liver Fibrosis Test Using Shear Wave Elastography
  Ji Won Han
  The Korean Journal of Medicine.2025; 100(1): 26.     CrossRef
• Mitochondrial mt12361A>G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes
  Ming-Ying Lu, Yu-Ju Wei, Chih-Wen Wang, Po-Cheng Liang, Ming-Lun Yeh, Yi-Shan Tsai, Pei-Chien Tsai, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Yi-Hung Lin, Tyng-Yuan Jang, Ming-Yen Hsieh, Zu-Yau Lin, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Ch
  World Journal of Gastroenterology.2025;[Epub]     CrossRef
• Unlocking the potential of THR-β agonist therapies: resmetirom’s chemistry, biology, and patent insights
  Khushi Dahiya, Mahesh Palkar, Sanjay Sharma
  Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(8): 9703.     CrossRef
• Shared genetic architecture between metabolic dysfunction-associated steatotic liver disease and cardiometabolic traits comorbidities: a genome-wide pleiotropic and multi-omics study
  Xuan-Yu Wang, Qiong Lyu, Yang-Yang Zhang, Yue Su, Hongjie Zhao, Hui-Hui Shen, Ying-Yu Xie
  Metabolism and Target Organ Damage.2025;[Epub]     CrossRef
• From cooperation to collapse: systemic failure in liver disease through a sociological lens
  Junyu Wang, Jingting Lei, Martin C. Harmsen, Han Moshage
  Exploration of Digestive Diseases.2025;[Epub]     CrossRef
• Sustainable HPLC Method for Resmetirom, a Novel THR-β Agonist: Development, Validation and Greenness Assessment
  Khushi Dahiya, Sanjay Sharma
  Chromatographia.2025; 88(9): 717.     CrossRef
• Integrated stress response-mediated metabolic reprogramming drives hepatic stellate cell activation and liver fibrosis via the noncanonical EIF3d-ATF4-S100P signaling pathway
  Simin Yang, Hongli Zhang, Xiaoyan Sun, Zhengyang Chen, Zhentian Nie, Yuting Li, Xiaohan Liu, Yawei Kong, Ziyu Wang, Wenjing Zai, Shan Gao, Wei Chen
  Redox Biology.2025; 88: 103905.     CrossRef
• Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation
  Byeong Hyun Min, Shivani Devi, Goo Hyun Kwon, Haripriya Gupta, Jin-Ju Jeong, Satya Priya Sharma, Sung-Min Won, Ki-Kwang Oh, Sang Jun Yoon, Hee Jin Park, Jung A Eom, Min Kyo Jeong, Ji Ye Hyun, Nattan Stalin, Tae-Sik Park, Jieun Choi, Do Yup Lee, Sang Hak H
  Gut Microbes.2024;[Epub]     CrossRef
• From Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Steatotic Liver Disease: Out with the Old, in with the New
  Iyiad Alabdul Razzak, Mazen Noureddin, Hirsh Trivedi
  Journal of Clinical Medicine.2024; 13(3): 880.     CrossRef
• Impact of MAFLD criteria on postoperative recurrence of non-B, non-C HCC
  Yusuke Johira, Takashi Nakahara, Kenji Yamaoka, Yasutoshi Fujii, Shinsuke Uchikawa, Hatsue Fujino, Atsushi Ono, Eisuke Murakami, Tomokazu Kawaoka, Daiki Miki, Masataka Tsuge, Shiro Oka
  European Journal of Gastroenterology & Hepatology.2024; 36(4): 430.     CrossRef
• TM7SF3 controls TEAD1 splicing to prevent MASH-induced liver fibrosis
  Roi Isaac, Gautam Bandyopadhyay, Theresa V. Rohm, Sion Kang, Jinyue Wang, Narayan Pokhrel, Sadatsugu Sakane, Rizaldy Zapata, Avraham M. Libster, Yaron Vinik, Asres Berhan, Tatiana Kisseleva, Zea Borok, Yehiel Zick, Francesca Telese, Nicholas J.G. Webster,
  Cell Metabolism.2024; 36(5): 1030.     CrossRef
• Dual-etiology MAFLD: the interactions between viral hepatitis B, viral hepatitis C, alcohol, and MAFLD
  Chun-Jen Liu, Wai Kay Seto, Ming-Lung Yu
  Hepatology International.2024; 18(S2): 897.     CrossRef
• Collagen-rich liver-derived extracellular matrix hydrogels augment survival and function of primary rat liver sinusoidal endothelial cells and hepatocytes
  Junyu Wang, Fenghua Zhao, Linda A. Brouwer, Manon Buist-Homan, Justina C. Wolters, Han Moshage, Martin C. Harmsen
  International Journal of Biological Macromolecules.2024; 278: 134717.     CrossRef
• Incretin-based therapy in the management of metabolic dysfunction-associated steatotic liver disease (MASLD): one piece of the puzzle: Editorial on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fa
  Tian-Yi Ren, Mohammed Eslam, Jian-Gao Fan
  Clinical and Molecular Hepatology.2024; 30(4): 649.     CrossRef
• Pathogenesis and management of metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma: a narrative review
  Han Ah Lee
  The Ewha Medical Journal.2024;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Sarcopenia and MASLD: novel insights and the future
  Chang-Hai Liu, Qing-Min Zeng, Won Kim, Seung Up Kim, Zobair M. Younossi, Giovanni Targher, Christopher D. Byrne, Christos S. Mantzoros, Phunchai Charatcharoenwitthaya, Isabelle Anne Leclercq, Manuel Romero-Gómez, Hong Tang, Ming-Hua Zheng
  Nature Reviews Endocrinology.2026; 22(3): 139.     CrossRef
• Intrinsic capacity, genetic susceptibility, and the risks of metabolic dysfunction–associated steatotic liver disease and cirrhosis
  Zhuoshuai Liang, Hongrui Zhang, Huizhen Jin, Wenhui Gao, Ruofei Li, Xinmeng Hu, Yi Cheng, Lingfei Guo, Yawen Liu
  International Journal of Surgery.2026; 112(1): 780.     CrossRef
• Sarcopenia as a risk factor for nonalcoholic fatty liver disease and liver fibrosis: an updated systematic review and meta-analysis
  Xinrong Zuo, Doudou Chen, Yi Kang, Xinyi Hu, Yarong Zhang, Kuo Tang, Junhua Shi, Tao Li, Wangning Shangguan
  Frontiers in Nutrition.2026;[Epub]     CrossRef
• Type 2 diabetes mellitus
  Melanie J. Davies, Soo Lim, Tommy Slater, Jonathan Goldney, Athena Philis-Tsimikas, Denise R. Franco, Roberta Lamptey, Thomas Yates, Tsvetalina Tankova, Ildiko Lingvay
  Nature Reviews Disease Primers.2026;[Epub]     CrossRef
• Refining intergenerational MASLD risk: are measurement and mediation shaping the signal?
  Tien Manh Huynh, Thinh Ong, Naveen Gautam, Hung Song Nguyen
  Gut.2026; : gutjnl-2026-338664.     CrossRef
• CT-assessed abdominal visceral adiposity and MASLD: a sex-stratified cross-sectional analysis
  Linying Xu, Ting Chen, Yitian Xie, Xueyu Xiang, Yupeng Liu, Chongyong Xu, Shuran Wang
  Frontiers in Nutrition.2026;[Epub]     CrossRef
• Sarcopenia in patients with non-alcoholic fatty liver disease: pathogenesis, diagnosis and treatment (expert opinion)
  L. Yu. Ilchenko, V. A. Akhmedov, E. V. Vinnitskaya, E. I. Dedov, R. G. Myazin, I. G. Nikitin, A. S. Tikhomirova, I. E. Khoroshilov, G. V. Shavkuta, O. A. Ettinger, I. G. Adamova, L. B. Lazebnik
  Experimental and Clinical Gastroenterology.2026; (4): 3.     CrossRef
• Effects of GLP‐1 Receptor Agonists on Muscle Mass, Strength, and Quality in MASLD: A Systematic Review
  Fernando Iorra, Tanya Jayakar, Michael Yee, Mark R. Thursz, Beatriz D. Schaan, Pinelopi Manousou
  Liver International.2026;[Epub]     CrossRef
• Association of Abdominal Myosteatosis and Visceral Fat Obesity with Arterial Stiffness
  Min Jung Lee, Hong-Kyu Kim, Eun Hee Kim, Sung Jin Bae, Hyo-Jung Nam, Sang Hoon Lee, Chang Hee Jung, Woo Je Lee
  Endocrinology and Metabolism.2026;[Epub]     CrossRef
• Beyond BMI: Reassessing the Prevalence of Obesity in Patients With MASLD Under the Lancet Commission Diagnostic Criteria
  Ru‐Tao Lin, Ren‐Qiang Zeng, Xu‐Ting Shen, Qin‐Mei Sun, Xin Xin, Jia‐Mei Chen, Yi‐Yang Hu, Qin Feng
  Diabetes, Obesity and Metabolism.2026;[Epub]     CrossRef
• From body composition to reflux esophagitis: an interpretable machine learning model based on CT-derived features
  Tianyi Wang, Lu Chen, Yajie Li, Qi Zhang, Xilong Ou, Qin Lu
  Frontiers in Physiology.2026;[Epub]     CrossRef
• Visceral obesity exacerbates perioperative muscle loss and impairs survival in colorectal cancer
  Yun Wang, Jun Bu, Chen-Yang Zhan, Da-Lin Xu, Jia-Qi Hu, Ming-Hao Zhang, Ke-Jin Zhu, Yang Qi
  World Journal of Gastrointestinal Surgery.2026;[Epub]     CrossRef
• The Relationship Between Remnant Cholesterol and Visceral Adipose Tissue: A National Cross-Sectional Study
  Zhaoxiang Wang, Shao Zhong, Menghuan Wu, Xuejing Shao, Tian Gu, Mengjiao Xu, Qichao Yang
  Hormone and Metabolic Research.2025; 57(01): 47.     CrossRef
• Frailty and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases
  Qi Zhong, Rui Zhou, Yi-Ning Huang, Rui-Dian Huang, Fu-Rong Li, Hao-Wen Chen, Yan-Fei Wei, Kuan Liu, Bi-Fei Cao, Kai-Yue Liao, Zheng-Yun Xu, Shi-Ao Wang, Xian-Bo Wu
  Journal of Hepatology.2025; 82(3): 427.     CrossRef
• Statin use and liver-related prognosis among patients with MASLD
  Byungyoon Yun, Heejoo Park, Jian Lee, Beom Kyung Kim, Jin-Ha Yoon
  JHEP Reports.2025; 7(4): 101313.     CrossRef
• AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B
  Hyunjae Shin, Moon Haeng Hur, Byeong Geun Song, Soo Young Park, Gi-Ae Kim, Gwanghyeon Choi, Joon Yeul Nam, Minseok Albert Kim, Youngsu Park, Yunmi Ko, Jeayeon Park, Han Ah Lee, Sung Won Chung, Na Ryung Choi, Min Kyung Park, Yun Bin Lee, Dong Hyun Sinn, Se
  Journal of Hepatology.2025; 82(6): 1080.     CrossRef
• Lymph Node Adiposity and Metabolic Dysfunction-Associated Steatotic Liver Disease
  Jessica M. Rubino, Natalie Yanzi Ring, Krishna Patel, Xiaoqing Xia, Todd A. MacKenzie, Roberta M. diFlorio-Alexander
  Biomedicines.2025; 13(1): 80.     CrossRef
• Is type 2 diabetes a link between lung function and metabolic dysfunction–associated steatotic liver disease? Insights from population studies and Mendelian randomization
  Runmin Cao, Yurun Zhang, Ling Cao, Honghe Jiang
  European Journal of Gastroenterology & Hepatology.2025; 37(5): 652.     CrossRef
• A cross-sectional study of risk factors associated with sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease
  Johnny Amer, Qusay Abdoh, Zaina Salous, Eithar Abu Alsoud, Sama AbuBaker, Ahmad Salhab, Manal Badrasawi
  Frontiers in Medicine.2025;[Epub]     CrossRef
• The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
  Mohammed Eslam, Jian-Gao Fan, Ming-Lung Yu, Vincent Wai-Sun Wong, Ian Homer Cua, Chun-Jen Liu, Tawesak Tanwandee, Rino Gani, Wai-Kay Seto, Shahinul Alam, Dan Yock Young, Saeed Hamid, Ming-Hua Zheng, Takumi Kawaguchi, Wah-Kheong Chan, Diana Payawal, Soek-S
  Hepatology International.2025; 19(2): 261.     CrossRef
• Sarcopenia and non-alcoholic fatty liver disease - complex pathogenetic relationships
  V. A. Akhmedov, V. S. Marinenko
  Experimental and Clinical Gastroenterology.2025; (9): 110.     CrossRef
• Effects of Pemafibrate on Serum Carnitine and Plasma Myostatin in Patients With Metabolic Dysfunction Associated Steatotic Liver Disease
  Ryohei Tanigawa, Atsushi Nakajima, Yuichiro Eguchi, Hirokazu Takahashi, Rohit Loomba, Hideki Suganami, Masaya Tanahashi, Hidenori Arai
  JCSM Communications.2025;[Epub]     CrossRef
• Metabolic dysfunction-associated steatotic liver disease (MASLD): Exploring systemic impacts and innovative therapies
  Parag Jain, Akanksha Jain, Rohitas Deshmukh, Pradeep Samal, Trilochan Satapathy, Ajazuddin
  Clinics and Research in Hepatology and Gastroenterology.2025; 49(6): 102584.     CrossRef
• Comparative Hepatic Outcomes of SGLT2i or DPP4i Compared to GLP‐1RA in CHB and T2DM Patients
  Byungyoon Yun, Juyeon Oh, Heejoo Park, Jian Lee, Beom Kyung Kim, Jin‐Ha Yoon
  Liver International.2025;[Epub]     CrossRef
• Skeletal muscle and MASLD: Mechanistic and clinical insights
  Thomas Marjot, Matthew J. Armstrong, Jonathan G. Stine
  Hepatology Communications.2025;[Epub]     CrossRef
• Metabolic dysfunction-associated steatotic liver disease: A story of muscle and mass
  Vasily Isakov
  World Journal of Gastroenterology.2025;[Epub]     CrossRef
• Association of lean metabolic dysfunction‐associated steatotic liver disease with carotid plaque progression in patients with type 2 diabetes mellitus
  Youngjoon Kim, Yongin Cho, Yong‐ho Lee, Da Hea Seo, Seong Hee Ahn, Seongbin Hong, So Hun Kim
  Journal of Diabetes Investigation.2025; 16(9): 1713.     CrossRef
• Role of estimated glucose disposal rate in predicting myosteatosis: Insights from abdominal CT analysis
  Myung Jin Kim, Yun Kyung Cho, Eun Hee Kim, Min Jung Lee, Woo Je Lee, Hong-Kyu Kim, Chang Hee Jung
  Nutrition, Metabolism and Cardiovascular Diseases.2025; 35(12): 104225.     CrossRef
• Non-alcoholic fatty liver disease, metabolic dysfunction and sarcopenia
  G.V. Shavkuta, V.A. Gavrilyukov, V.N. Kovalenko, A.S. Zubkova, Z.M. Nalgieva
  Terapevt (General Physician).2025; (6): 60.     CrossRef
• Thigh Muscles and Metabolic Dysfunction‐Associated Steatotic Liver Disease: Findings From the SCAPIS/IGT‐Microbiota Study
  Amar Osmancevic, Anders Gummesson, Matthew Allison, Joel Kullberg, Ying Li, Göran Bergström, Bledar Daka
  Liver International.2025;[Epub]     CrossRef
• Influence of Matcha and Tea Catechins on the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)—A Review of Patient Trials and Animal Studies
  Danuta I. Kosik-Bogacka, Katarzyna Piotrowska
  Nutrients.2025; 17(15): 2532.     CrossRef
• Associations of child-to-adult body size change with risk of hypertension and metabolic dysfunction-associated steatotic liver disease: a population-based cohort study of 226,420 individuals
  Fengyuan Tang, Wenqianzi Yang, Weijia Wu, Shengxuan Jin, Xuemei Zhen, Hengjin Dong
  BMC Public Health.2025;[Epub]     CrossRef
• The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with early onset type 2 diabetes with NAFLD: a cross-sectional study in China
  Nini Wu, Yingqun Ni, Rilong Huang, Junhua Wang, Meimei Li, Haiying Hu, Yuanyuan Zhang, Juyi Li, Jinjun Zhang
  Frontiers in Nutrition.2025;[Epub]     CrossRef
• The Basics of Metabolic Dysfunction–Associated Steatotic Liver Disease for Cardiologists
  Muhammad Shahzeb Khan, Syed Sarmad Javaid, Amreen Dinani, Kara Wegermann, Ambarish Pandey, Ankeet S. Bhatt, Mark Muthiah, Harriette G.C. Van Spall, Faiez Zannad, Javed Butler, Michael L. Volk, Marat Fudim
  JACC.2025; 86(20): 1861.     CrossRef
• Prevalence and impact on the outcome of myosteatosis in patients with cirrhosis: a systematic review and meta-analysis
  Aikaterini Kamiliou, Vasileios Lekakis, Lampros Chrysavgis, Evangelos Cholongitas
  Hepatology International.2024; 18(2): 688.     CrossRef
• Prevalence of and Impact on the Outcome of Myosteatosis in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
  Aikaterini Kamiliou, Vasileios Lekakis, George Xynos, Evangelos Cholongitas
  Cancers.2024; 16(5): 952.     CrossRef
• Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting
  Alina M. Allen, Michael Charlton, Kenneth Cusi, Stephen A. Harrison, Kris V. Kowdley, Mazen Noureddin, Jay H. Shubrook
  Postgraduate Medicine.2024; 136(3): 229.     CrossRef
• Metabolic Dysfunction–Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options
  Piero Portincasa, Mohamad Khalil, Laura Mahdi, Valeria Perniola, Valeria Idone, Annarita Graziani, Gyorgy Baffy, Agostino Di Ciaula
  International Journal of Molecular Sciences.2024; 25(11): 5640.     CrossRef
• Association between metabolic dysfunction‐associated steatotic liver disease and myosteatosis measured by computed tomography
  Myung Jin Kim, Yun Kyung Cho, Eun Hee Kim, Min Jung Lee, Woo Je Lee, Hong‐Kyu Kim, Chang Hee Jung
  Journal of Cachexia, Sarcopenia and Muscle.2024; 15(5): 1942.     CrossRef
• The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis
  Xiaoyan Li, Jie He, Qiuhua Sun
  Clinical Nutrition.2024; 43(9): 2005.     CrossRef
• Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular c
  Toru Nakamura, Masahito Nakano, Tsubasa Tsutsumi, Keisuke Amano, Takumi Kawaguchi
  Clinical and Molecular Hepatology.2024; 30(4): 705.     CrossRef
• Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated with Increased Risk of Kidney Cancer: A Nationwide Study
  Juyeon Oh, Beom Kyung Kim, Jin-Ha Yoon, Hyung Ho Lee, Heejoo Park, Jian Lee, Youngsun Park, Byungyoon Yun, Jinsoo Chung
  Cancers.2024; 16(18): 3161.     CrossRef
• Diagnosis and management of metabolic dysfunction- associated steatotic liver disease in South Asians- A clinical review
  Prajith Raj Ramesh, Priya Krishnan, Samyuktha Prabu, Varshini Srinivasan, Varalakshmi Niranjan
  Obesity Pillars.2024; 12: 100142.     CrossRef
• Diagnosis and Management of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review
  Basile Njei, Prince Ameyaw, Yazan Al-Ajlouni, Lea-Pearl Njei, Sarpong Boateng
  Cureus.2024;[Epub]     CrossRef
• Reply to correspondence on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: a network meta-analysis”
  Tian-Yi Ren, Mohammed Eslam, Jian-Gao Fan
  Clinical and Molecular Hepatology.2024; 30(4): 1039.     CrossRef
• Correspondence to editorial on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: a network meta-analysis”
  Hayeon Kim, Min Jeong Park, Myeong Gyu Kim, Kyungim Kim
  Clinical and Molecular Hepatology.2024; 30(4): 989.     CrossRef
• Correlation and predictive value of novel anthropometric indicators with adult sarcopenia and sarcopenia obesity
  Xue Wu, Ziang Chen, Yuanhui Zhao, Hong Ren
  Scientific Reports.2024;[Epub]     CrossRef
• Sarcopenia as a Risk Factor for Mortality in NAFLD: How Should We Diagnose It?
  Catherine Stankevicius, Rachel H. Davis, Dep Huynh, Martine Hatzi, Stephanie Morgillo, Alice S. Day
  Journal of Digestive Diseases.2024; 25(11-12): 645.     CrossRef
• Non-alcoholic fatty liver disease in people with normal body weight
  S. V. Turkina, I. A. Tyshchenko, M. N. Titarenko
  Experimental and Clinical Gastroenterology.2024; (10): 36.     CrossRef
• Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
  Eugene Han, Yong-ho Lee
  Clinical and Molecular Hepatology.2023; 29(4): 980.     CrossRef
• Sodium-glucose co-transporter 2 inhibitors and Sarcopenia: A controversy that must be solved
  Baris Afsar, Rengin Elsurer Afsar
  Clinical Nutrition.2023; 42(12): 2338.     CrossRef
• Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
  Wah-Kheong Chan, Kee-Huat Chuah, Ruveena Bhavani Rajaram, Lee-Ling Lim, Jeyakantha Ratnasingam, Shireene Ratna Vethakkan
  Journal of Obesity & Metabolic Syndrome.2023; 32(3): 197.     CrossRef
• The newly proposed Metabolic Score for Visceral Fat is a reliable tool for identifying non-alcoholic fatty liver disease, requiring attention to age-specific effects in both sexes
  Maobin Kuang, Jiajun Qiu, Dongdong Li, Chong Hu, Shuhua Zhang, Guotai Sheng, Yang Zou
  Frontiers in Endocrinology.2023;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Cohort Profile: Taizhou Study of Liver Diseases (T-SOLID)
  Zhenqiu Liu, Yanfeng Jiang, Chen Suo, Huangbo Yuan, Ziyu Yuan, Tiejun Zhang, Li Jin, Xingdong Chen
  International Journal of Epidemiology.2025;[Epub]     CrossRef
• Development of a simple metabolic score to predict liver fibrosis risk in chronic hepatitis B patients: A retrospective cross-sectional study
  Li Liu, Peng Ye, Qiuping Gu, Ling Zeng, Lijuan Liang, Yingfeng Wei
  Journal of International Medical Research.2025;[Epub]     CrossRef
• Hepatitis B Virus and microRNAs: A Bioinformatics Approach
  Verdiana Zulian, Giulia Fiscon, Paola Paci, Anna Rosa Garbuglia
  International Journal of Molecular Sciences.2023; 24(24): 17224.     CrossRef

Citations

Citations to this article as recorded by  

• MAST versus FAST for active fibrotic MASH: a meta-analysis supporting risk-stratified diagnostic pathways
  Shengfang Liu, Qingjuan Zhang, Lijing Wang, Qin Tang, Bingtao Hu
  Frontiers in Medicine.2026;[Epub]     CrossRef
• Evolving B-mode ultrasound-based techniques for assessing metabolic dysfunction-associated steatotic liver disease: Now and beyond
  Walaa Abdelhamed, Mohamed Elbadry, Mohamed El-Kassas
  Liver Research.2026;[Epub]     CrossRef
• Collagen fibers quantification for liver fibrosis assessment using linear dichroism photoacoustic microscopy
  Yang Qiu, Honghui Li, Kun Yu, Jiali Chen, Li Qi, Yinghua Zhao, Liming Nie
  Photoacoustics.2025; 42: 100694.     CrossRef

Citations

Citations to this article as recorded by  

• Evolution of Multivalent Aptamer Corona for High‐Throughput Multiplexed Detection of Multiple Cancers
  Mengjie Wang, Baichuan Jin, Xin Dai, Haozhe Huang, Qiqi Liu, Jianqing Zhu, Haixing Ju, Qixun Chen, Yongmei Song, Weihong Tan, Yuan Liu
  Advanced Science.2026;[Epub]     CrossRef
• Identification of Circulating MiR-4651 as Novel Biomarker for Metabolic Dysfunction–associated Steatotic Liver Disease
  Mélanie Kirchmeyer, Anthoula Gaigneaux, Florence A. Servais, Anita Arslanow, Claudia Rubie, Markus Casper, Matthias Glanemann, María L. Martínez-Chantar, Marcin Krawczyk, Frank Lammert, Iris Behrmann
  Gastro Hep Advances.2026; 5(2): 100839.     CrossRef
• FIB‐4 Serves as a Referral Index for Coronary Artery Calcification in Patients With MASLD
  Ya‐Chin Huang, Chih‐Wen Wang, Jiun‐Chi Huang, Po‐Cheng Liang, Ming‐Lun Yeh, Yi‐Yu Chen, Yi‐Hung Lin, Tyng‐Yuan Jang, Yu‐Ju Wei, Ming‐Yen Hsieh, Chao‐Kuan Huang, Hsu‐Han Chien, Chia‐Jen Wu, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang, Chia‐I Lin, Chung‐Fen
  Journal of Gastroenterology and Hepatology.2026; 41(1): 332.     CrossRef
• I-FABP, citrulline and non-invasive liver dysfunction indices in patients with depression – cross-sectional study results
  Jakub Rogalski, Joanna Grzelczyk, Aleksandra Margulska, Grzegorz Mirocha, Grażyna Budryn, Dominik Strzelecki, Oliwia Gawlik-Kotelnicka
  BMC Gastroenterology.2026;[Epub]     CrossRef
• New Treatment Options for MASLD Patients with Type 2 Diabetes
  Andrea Mega, Chiara Turri, Luca Marzi, Marco Dauriz, Rodolfo Sacco, Annarosa Floreani, Cristina Stasi
  Life.2026; 16(2): 254.     CrossRef
• Performance of three clinical scores for steatosis and steatohepatitis and their interaction with metabolic syndrome in obese individuals
  Giovani Schulte Farina, Bárbara Brambilla, Emanuelle Mendonça Pandolfo, Laura Kalil Nader Lazzaretti, Stéfano Mateus Schio Kuiava, Ana Maria Graciolli, Vitória Maria Kriger, Carlos Henrique Dal Bem Fistarol, Augusto Cardoso Sgarioni, Henrique Prataviera G
  World Journal of Hepatology.2026;[Epub]     CrossRef
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Limosilactobacillus fermentum K8-Lb1 Postbiotic on Weight Management and Metabolic Health Outcomes
  Ekaterina Papazova, Susanne Mitschke, Christiane Laue, Jürgen Schrezenmeir
  Nutrients.2026; 18(8): 1174.     CrossRef
• Gut microbiota–derived indole-3-propionic acid alleviates endoplasmic reticulum stress by regulating FMO2 in MASLD
  Yue Luo, Yuefeng Zhang, Qian Zhang, Xiaohan Li, Kaiwei Cai, Yaning Xu, Ruirui Zhao, Saixuan Zhang, Xinyu Bai, Haopeng Chen, Hao Li, Yanjun Hong, Qiongfeng Liao, Zhiyong Xie
  Hepatology Communications.2026;[Epub]     CrossRef
• Performance of Noninvasive Indices for Discrimination of Metabolic Dysfunction-Associated Steatotic Liver Disease in Young Adults
  Jaejun Lee, Chang In Han, Dong Yeup Lee, Pil Soo Sung, Si Hyun Bae, Hyun Yang
  Gut and Liver.2025; 19(1): 116.     CrossRef
• Noninvasive identification of metabolic dysfunction–associated steatohepatitis (INFORM MASH): a retrospective cohort and disease modeling study
  G. Craig Wood, Anthony Hoovler, Rakesh Luthra, Christopher D. Still, Hamzah Shariff, Matthew Still, Jonathan Hayes, Peter Benotti, Chioma Uzoigwe
  Expert Review of Gastroenterology & Hepatology.2025; 19(4): 427.     CrossRef
• Updated recommendations for the management of metabolic dysfunction–associated steatotic liver disease (MASLD) by the Latin American working group
  Luis Antonio Diaz, Juan Pablo Arab, Francisco Idalsoaga, Javiera Perelli, Javier Vega, Melisa Dirchwolf, Javiera Carreño, Bárbara Samith, Cynthia Valério, Rodrigo Oliveira Moreira, Mónica Acevedo, Javier Brahm, Nelia Hernández, Adrian Gadano, Claudia P. O
  Annals of Hepatology.2025; 30(2): 101903.     CrossRef
• Atherogenic index of plasma identifies subjects with severe liver steatosis
  Carlo De Matteis, Fabio Novielli, Ersilia Di Buduo, Maria Arconzo, Raffaella Maria Gadaleta, Marica Cariello, Antonio Moschetta, Lucilla Crudele
  Scientific Reports.2025;[Epub]     CrossRef
• Construction and evaluation of a diagnostic model for metabolic dysfunction-associated steatotic liver disease based on advanced glycation end products and their receptors
  Xiao Cao, Xiaohua Xiao, Peipei Jiang, Nian Fu
  Frontiers in Medicine.2025;[Epub]     CrossRef
• Analysis the Mechanism of Herba Artemisiae scopariae and Folium nelumbinis in the Treatment of Non-Alcoholic Fatty Liver Disease Based on Network Pharmacology
  鑫凤 娄
  Traditional Chinese Medicine.2025; 14(04): 1253.     CrossRef
• Management of metabolic dysfunction–associated steatotic liver disease (MASLD)—An expert consensus statement from Indian diabetologists' perspective
  Abdul Hamid Zargar, Anil Bhansali, Anirban Majumdar, Anuj Maheshwari, Arpandev Bhattacharyya, Arundhati Dasgupta, Banshi Damodarlal Saboo, Bipin Kumar Sethi, Debmalya Sanyal, Krishna G. Seshadri, Neeta Rohit Deshpande, Nitin Kapoor, Om Jitendra Lakhani, P
  Diabetes, Obesity and Metabolism.2025; 27(S4): 3.     CrossRef
• The value of ultrasonic attenuation parameters and serum indicators on MASLD patients with liver fat degenerationality
  Yan Liu, Wen Kang, Jingya Su, Yin Yang, Kui Li, Juntao Yang
  Journal of Radiation Research and Applied Sciences.2025; 18(3): 101647.     CrossRef
• Associations Between Shift Work, Sociodemographic and Lifestyle Characteristics, Body Measurements, and MASLD
  Javier Tosoratto, Pedro Juan Tárraga López, Ángel Arturo López-González, Carla Busquets-Cortes, Joan Obrador de Hevia, José Ignacio Ramirez-Manent
  Life.2025; 15(6): 961.     CrossRef
• L-Phenylalanine promotes liver steatosis by inhibiting BNIP3-mediated mitophagy
  Ying Sun, Lingli Cai, Bowei Yu, Haojie Zhang, Ziteng Zhang, Xiaoqin Xu, Yuefeng Yu, Jiang Li, Chi Chen, Fangzhen Xia, Yingli Lu, Kun Zhang, Ningjian Wang
  Molecular Medicine.2025;[Epub]     CrossRef
• MOFI-FL, a novel score for detecting hepatic steatosis and predicting cardiometabolic mortality
  Juan Reyes-Barrera, Rosalinda Posadas-Sánchez, Gilberto Vargas-Alarcón, Guillermo C. Cardoso-Saldaña, Paloma Almeda-Valdes, Omar Yaxmehen Bello Chavolla, Luis Ortiz-Hernandez, Neftali Eduardo Antonio-Villa
  Scientific Reports.2025;[Epub]     CrossRef
• Quantification of liver steatosis of metabolic dysfunction-associated steatotic liver disease based on body composition analysis
  Toshikazu Kohira, Satoshi Oeda, Erina Eto, Yoshihito Kubotsu, Misa Norita, Kaori Inoue, Nagisa Hara, Shotaro Noge, Kenichi Tanaka, Shigenobu Yoshimura, Noriko Oza, Keizo Anzai, Yuichiro Eguchi, Cheng Han Ng, Daniel Q. Huang, Mark D. Muthiah, Atsushi Kawag
  Scientific Reports.2025;[Epub]     CrossRef
• Metabolic and hepatic biomarkers associated with MASLD in the Chinese population
  Hua Chen, Zexu Chen, Xinyan Bai, Zhaohua Li, Songqi Huang, Dawei Lu, Jue Li, Yunfei Wang, Lu Han, Kun Xia, Shuqiong Huang
  Scientific Reports.2025;[Epub]     CrossRef
• Discovery of ultrasound-derived fat fraction as a non-invasive tool for MASLD diagnosis
  Huiru Jin, Mengfan Jiao, Chengxiao Yu, Tingting Ren, Qingling Chen, Zixing Dai, Erfu Xie, Longfeng Jiang, Yuwen Li
  European Journal of Medical Research.2025;[Epub]     CrossRef
• Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD): Mechanisms, Clinical Implications and Therapeutic Advances
  Dalia M. Miller, Kiana F. McCauley, Kimberly J. Dunham‐Snary
  Endocrinology, Diabetes & Metabolism.2025;[Epub]     CrossRef
• From fatty liver indices to the Zhejiang University index: Re-shaping risk stratification of metabolic liver disease in diabetes
  Mostafa M Gouda
  World Journal of Diabetes.2025;[Epub]     CrossRef
• The interplay of metabolic dysfunction‐associated fatty liver disease and viral hepatitis on liver disease severity: A large community‐based study in a viral endemic area
  Chung‐Feng Huang, Po‐Cheng Liang, Pei‐Chien Tsai, Yu‐Ju Wei, Ching‐I Huang, Chih‐Wen Wang, Tyng‐Yuan Jang, Ming‐Lun Yeh, Po‐Yao Hsu, Ming‐Yen Hsieh, Yi‐Hung Lin, Chia‐Yen Dai, Wan‐Long Chuang, Jee‐Fu Huang, Ming‐Lung Yu
  Journal of Gastroenterology and Hepatology.2024; 39(1): 193.     CrossRef
• Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
  Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, Mohammad Zulqurnain Haider, Mohammed Imad Malki, Abdel-Naser Elzouki
  Frontiers in Medicine.2024;[Epub]     CrossRef
• Prevalence of at‐risk MASH, MetALD and alcohol‐associated steatotic liver disease in the general population
  Carolin V. Schneider, Kai Markus Schneider, Anastasia Raptis, Helen Huang, Christian Trautwein, Rohit Loomba
  Alimentary Pharmacology & Therapeutics.2024; 59(10): 1271.     CrossRef
• Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population
  Nicholas W.S. Chew, Xin Hui Pan, Bryan Chong, Chanchal Chandramouli, Mark Muthiah, Carolyn S.P. Lam
  Diabetes Research and Clinical Practice.2024; 211: 111652.     CrossRef
• High-Sensitivity C-Reactive Protein Levels in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Alcohol-Associated Liver Disease (MetALD), and Alcoholic Liver Disease (ALD) with Metabolic Dysfunction
  Seong-Uk Baek, Jin-Ha Yoon
  Biomolecules.2024; 14(11): 1468.     CrossRef
• Fatty Acids and Bilirubin as Intrinsic Autofluorescence Serum Biomarkers of Drug Action in a Rat Model of Liver Ischemia and Reperfusion
  Anna C. Croce, Andrea Ferrigno, Giuseppina Palladini, Barbara Mannucci, Mariapia Vairetti, Laura G. Di Pasqua
  Molecules.2023; 28(9): 3818.     CrossRef
• The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
  Teodora Biciusca, Sorina Ionelia Stan, Mara Amalia Balteanu, Ramona Cioboata, Alice Elena Ghenea, Suzana Danoiu, Ana-Maria Bumbea, Viorel Biciusca
  Diagnostics.2023; 13(21): 3316.     CrossRef
• Quantitative ultrasound envelope statistics imaging as a screening approach for pediatric hepatic steatosis and liver fibrosis: using biomarker and transient elastography as reference standards
  Chiao-Shan Hsieh, Ming-Wei Lai, Chien-Chang Chen, Hsun-Chin Chao, Chiao-Yin Wang, Yung-Liang Wan, Zhuhuang Zhou, Po-Hsiang Tsui
  Heliyon.2023; 9(12): e22743.     CrossRef
• Alcohol consumption and the risk of liver disease: a nationwide, population-based study
  Sang Yi Moon, Minkook Son, Yeo Wool Kang, Myeongseok Koh, Jong Yoon Lee, Yang Hyun Baek
  Frontiers in Medicine.2023;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Near-Infrared Fluorescent Lipid Droplet Polarity Probe for Distinguishing Different Liver Injury Diseases
  Xiaodong Tan, Yijia Liu, Siyu Jiang, Zhoupeng Zheng, Guoqiang Feng
  Chemical & Biomedical Imaging.2026; 4(5): 924.     CrossRef
• Evaluation of thyroid function in patients diagnosed with metabolic dysfunction-associated fatty liver disease: a cross-sectional study
  Ahmed M. Eldaba, Mona M. Watany, Galal El Din M. Elkassas, Rehab B. El sheshtawy
  Tanta Medical Journal.2026; 54(1): 143.     CrossRef
• Circulating hepatocyte-derived extracellular particles as potential biomarker of steatohepatitis progression to fibrogenesis: Exploring the impact of smoking
  Oumnia Masrour, Justine Morvan, Alison Rapin, Alexis Aimé, Agnès Burel, Valentine Genêt, Stéphanie Brisset, Dominique Lagadic-Gossmann, Edouard Bardou-Jacquet, Corinne Martin-Chouly
  Digestive and Liver Disease.2026; 58(3): 355.     CrossRef
• Performance of three clinical scores for steatosis and steatohepatitis and their interaction with metabolic syndrome in obese individuals
  Giovani Schulte Farina, Bárbara Brambilla, Emanuelle Mendonça Pandolfo, Laura Kalil Nader Lazzaretti, Stéfano Mateus Schio Kuiava, Ana Maria Graciolli, Vitória Maria Kriger, Carlos Henrique Dal Bem Fistarol, Augusto Cardoso Sgarioni, Henrique Prataviera G
  World Journal of Hepatology.2026;[Epub]     CrossRef
• A Standardized Extract of Centella asiatica (ECa 233) Protects Against Liver Injury and Fatty Liver in Wild‐Type and Beta‐Thalassemia Mice With Iron Overload
  Paranee Yatmark, Puntita Anutagerngkun, Somkiat Huaijantug, Mayuree H. Tantisira, Saovaros Svasti, Noppawan Phumala Morales, Anjali Chauhan
  Advances in Pharmacological and Pharmaceutical Sciences.2026;[Epub]     CrossRef
• Diagnostic performance of controlled attenuation parameter for grading hepatic steatosis in MASLD: an MRI-PDFF-referenced study in a Chinese cohort
  Siying Wang, Dongfang Shang, Chenlu Zhao, Lihui Zhang, Sutong Liu, Qing Zhao, Qiang Zhang, Wenxia Zhao
  Frontiers in Medicine.2026;[Epub]     CrossRef
• Three-Dimensional In Situ Sensing and Spatiotemporal Imaging Analysis of Dual Targets in Steatotic Liver Disease
  Meiqi Song, Ke Shen, Zhuo Liu, Jinghui Zhang, Congcong Jiang, Qinghua Hao, Wei Shen, Hian Kee Lee, Sheng Tang
  Analytical Chemistry.2026; 98(22): 16355.     CrossRef
• Relevance of lipid droplets in metabolic dysfunction-associated steatotic liver disease
  Ralf Weiskirchen, Amedeo Lonardo
  Expert Opinion on Therapeutic Targets.2026; 30(5): 473.     CrossRef
• Thyroid Stimulating Hormone Levels Are Related to Fatty Liver Indices Independently of Free Thyroxine: A Cross-Sectional Study
  Federica Sileo, Alessandro Leone, Ramona De Amicis, Andrea Foppiani, Laila Vignati, Francesca Menichetti, Giorgia Pozzi, Simona Bertoli, Alberto Battezzati
  Journal of Clinical Medicine.2025; 14(7): 2401.     CrossRef
• The application performance of MRI-PDFF detection values of different hepatic lobes in diagnosing liver steatosis
  Fengjie Qiao, Yan Xue, Chen Zou, Kun Liu, Jie Yuan, Longshan Ji, Lingying Huang, Man Li, Yueqiu Gao
  Clinical and Experimental Medicine.2025;[Epub]     CrossRef
• The value of ultrasonic attenuation parameters and serum indicators on MASLD patients with liver fat degenerationality
  Yan Liu, Wen Kang, Jingya Su, Yin Yang, Kui Li, Juntao Yang
  Journal of Radiation Research and Applied Sciences.2025; 18(3): 101647.     CrossRef
• Quantification of liver steatosis of metabolic dysfunction-associated steatotic liver disease based on body composition analysis
  Toshikazu Kohira, Satoshi Oeda, Erina Eto, Yoshihito Kubotsu, Misa Norita, Kaori Inoue, Nagisa Hara, Shotaro Noge, Kenichi Tanaka, Shigenobu Yoshimura, Noriko Oza, Keizo Anzai, Yuichiro Eguchi, Cheng Han Ng, Daniel Q. Huang, Mark D. Muthiah, Atsushi Kawag
  Scientific Reports.2025;[Epub]     CrossRef
• Discovery of ultrasound-derived fat fraction as a non-invasive tool for MASLD diagnosis
  Huiru Jin, Mengfan Jiao, Chengxiao Yu, Tingting Ren, Qingling Chen, Zixing Dai, Erfu Xie, Longfeng Jiang, Yuwen Li
  European Journal of Medical Research.2025;[Epub]     CrossRef
• Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
  Simei Huang, Yu Xi, Yanqing Hong, Chenliang Hu
  Hormone and Metabolic Research.2025; 57(10): 593.     CrossRef
• Current Update on Nomenclature, Diagnosis, and Management of Metabolic Dysfunction–associated Steatotic Liver Disease: Radiologists’ Perspective
  Eri G. Osta, Florentino Saenz Rios, Sriram Jaganathan, Courtney Thomas, Eugenia Tsai, Venkateswar Surabhi, Srinivasa R. Prasad, Venkata S. Katabathina
  RadioGraphics.2025;[Epub]     CrossRef
• 3D multiparametric ultrasound imaging of steatotic liver disease in a study with male rats
  Donghyun Lee, Jinseok Heo, Hyeonji Mun, Donghyeon Oh, Yongjoo Ahn, Chulhong Kim
  Nature Communications.2025;[Epub]     CrossRef
• Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitis
  Chung‐Feng Huang, Po‐Cheng Liang, Chih‐Wen Wang, Tyng‐Yuan Jang, Po‐Yao Hsu, Pei‐Chien Tsai, Yu‐Ju Wei, Ming‐Lun Yeh, Ming‐Yen Hsieh, Yi‐Hung Lin, Chao‐Kuan Huang, Chia‐Yen Dai, Jee‐Fu Huang, Wan‐Long Chuang, Ming‐Lung Yu
  The Kaohsiung Journal of Medical Sciences.2024; 40(4): 374.     CrossRef
• Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters
  Jeongin Yoo, Ijin Joo, Sun Kyung Jeon, Junghoan Park, Soon Ho Yoon
  European Radiology.2024; 34(9): 6205.     CrossRef
• Non–small cell lung cancer and immune checkpoint inhibitor therapy: does non-alcoholic fatty liver disease have an effect?
  Yi Li, Bingxin Gong, Yusheng Guo, Weiwei Liu, Chao Chen, Shanshan Jiang, Feng Pan, Jiyu Song, Lian Yang, Guofeng Zhou
  BMC Cancer.2024;[Epub]     CrossRef
• Head-to-head comparison of three different US-based quantitative parameters for hepatic steatosis assessment: a prospective study
  Yan Zhou, Mengjin Nie, Hongyu Zhou, Feng Mao, Lin Zhao, Jianmin Ding, Xiang Jing
  Abdominal Radiology.2024; 49(7): 2262.     CrossRef
• Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD
  Farah Abdelhameed, Chris Kite, Lukasz Lagojda, Alexander Dallaway, Kamaljit Kaur Chatha, Surinderjeet S. Chaggar, Maria Dalamaga, Eva Kassi, Ioannis Kyrou, Harpal S. Randeva
  Current Obesity Reports.2024; 13(3): 510.     CrossRef
• Maternal obesity and metabolic (dysfunction) associated fatty liver disease in pregnancy: a comprehensive narrative review
  Bianca M. Leca, Lukasz Lagojda, Chris Kite, Emmanouil Karteris, Eva Kassi, Harpal S. Randeva, Ioannis Kyrou
  Expert Review of Endocrinology & Metabolism.2024; 19(4): 335.     CrossRef
• Diagnosis and non‐invasive assessment of MASLD in type 2 diabetes and obesity
  Wah‐Kheong Chan, Salvatore Petta, Mazen Noureddin, George Boon Bee Goh, Vincent Wai‐Sun Wong
  Alimentary Pharmacology & Therapeutics.2024;[Epub]     CrossRef
• This Is What Metabolic Dysfunction–Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol
  Anja M. Fischer, Nazim Lechea, Harvey O. Coxson
  Seminars in Liver Disease.2024; 44(02): 226.     CrossRef
• Correspondence to editorial on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: a network meta-analysis”
  Hayeon Kim, Min Jeong Park, Myeong Gyu Kim, Kyungim Kim
  Clinical and Molecular Hepatology.2024; 30(4): 989.     CrossRef
• From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome – current insights and future directions
  Bruno Basil, Blessing K. Myke-Mbata, Onyinye E. Eze, Augustine U. Akubue
  Clinical Diabetes and Endocrinology.2024;[Epub]     CrossRef
• Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
  Lynna Alnimer, Mazen Noureddin
  Clinical and Molecular Hepatology.2023; 29(2): 394.     CrossRef
• Application of attenuation imaging for the detection of fatty liver in potential liver donors
  Jae Seok Bae, Dong Ho Lee, Kyung-Suk Suh, Kwang-Woong Lee, Nam-Joon Yi, Suk Kyun Hong
  European Journal of Radiology.2023; 166: 110958.     CrossRef
• Editorial: Will MRI‐PDFF become the new standard for steatosis assessment in NAFLD?
  Angeliki Pappa, Tobias Wenzl
  Alimentary Pharmacology & Therapeutics.2023; 58(3): 364.     CrossRef
• Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis
  Martina Maurelli, Paolo Gisondi, Francesco Bellinato, Alessandro Mantovani, Giovanni Targher, Giampiero Girolomoni
  Journal of Clinical Medicine.2023; 12(18): 6057.     CrossRef

Citations

Citations to this article as recorded by  

• Neutrophil extracellular traps mediate pathophysiology of hepatic cells during liver injury
  Ki M. Mak, Aditya C. Shekhar, Selena Y. Ding
  The Anatomical Record.2026; 309(1): 214.     CrossRef
• Alterations in Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension: Implications for Disease Progression
  Qun Zhang, Jinghua Cui, Yixin Hou, Lining Guo, Hai Li, Guiqin Zhou, Xiaojing Wang, Bingbing Zhu, Ke Shi, Yi Zhang, Yufei Bi, Yanqiu Li, Lina Sun, Ying Feng, Jing Yuan, Xianbo Wang
  Alimentary Pharmacology & Therapeutics.2026; 63(4): 538.     CrossRef
• Bielong Ruangan decoction inhibits tumor growth and improves immune response in a hepatocellular carcinoma mouse model through gut microbiota
  Ruoyu Wang, Dan Tang, Lingyu Wu, Longyun Ou, Lin Ding, Jiacheng Jiang, Yunan Wu
  The International Journal of Biochemistry & Cell Biology.2026; 190: 106873.     CrossRef
• Multitarget natural compounds taming NETosis: A translational strategy for cancer and inflammatory diseases
  Wentao Jia, Jinbo Zhang, Yan Shang, Shanrong Liu
  Cancer Letters.2026; 636: 218103.     CrossRef
• Gut microbiota's role in NAFLD- and HBV/HCV-related hepatocellular carcinoma: Mechanisms and therapeutic implications
  Gursimran Singh, Shazia Ansari, Satyam Yadav, Khadga Raj Aran
  Microbial Pathogenesis.2026; 211: 108273.     CrossRef
• A stage specific NETs-related signature in alcoholic steatohepatitis: from molecular subtyping to therapeutic vulnerabilities
  Wei Gao, Zhiyong Lin, Yuntao Bao, Mingjiang Liu, Guangtao Ma, Xianxiang Chen, Shuiping Yu, Yonglian Zeng
  Frontiers in Immunology.2026;[Epub]     CrossRef
• The landscape of gut microbiota in hepatocarcinogenesis: a comprehensive review of pathogenesis and therapeutic interventions
  Zhi-Bo Yan, Cheng-Long Han, Ji-Sen Jia, Han Li, Dong-Hai Lu, Qi-Hang Cao, Yu-Xuan Wang, Ke-Fan Jiao, Qiao He, Sheng-Xuan Peng, Dao-Lin Zhang, Qiang Wang, Tao Li
  International Journal of Surgery.2026; 112(1): 1673.     CrossRef
• Microbial Biomarkers for the Prevention and Diagnosis of Alcoholic Liver Disease
  Goo Hyun Kwon, Hyunjoon Park, Hyeong Seop Kim, Ki Kwang Oh, Jung A Eom, Kyeong Jin Lee, Min Ju Kim, Minsoo Kim, Jeong Su Kim, Sang Hak Han, Young Lim Ham, Ki Tae Suk
  Microorganisms.2026; 14(2): 449.     CrossRef
• The Molecular Network of Neutrophil Extracellular Traps in Hepatocellular Carcinoma: Biogenesis, Function, and Therapeutic Implications
  Chang Liu, Jienan Lu, Yang Tian, Sinan Lu, Weili Wang, Jun Jiang, Xiang Zheng, Sheng Yan
  Molecules.2026; 31(4): 749.     CrossRef
• Decoding the mechanistic basis of liver–muscle communication in health and disease
  Noha M. Gamil, Habiba A. Elsayed, Esraa T. Salah, Heba A. Mostafa, Riham A. El-Shiekh, Heba R. Ghaiad, Hebatollah E. Eitah
  Naunyn-Schmiedeberg's Archives of Pharmacology.2026;[Epub]     CrossRef
• Fucoidan alleviates chemotherapy-induced steatohepatitis by regulating the gut–liver axis
  Yihang Cai, Yongyi Chen, Xiqin Bian, Changlin Sun, Jing Cheng, Haibo Liu, Lai Jin, Jianxin Ma, Wentao Liu
  International Immunopharmacology.2026; 175: 116390.     CrossRef
• Targeting the Toll-Like Receptor 4 Ameliorates Heart Failure in Aged Mice by Inhibiting the Formation of Neutrophil Extracellular Traps
  H Liu, X Chen, Z Wu
  Physiological Research.2026; : 29.     CrossRef
• Gut–liver axis molecular mechanisms in alcohol-associated liver disease
  Yuxuan Jiang, Cristina Llorente
  Alcohol.2026; 133: 48.     CrossRef
• The versatile interplay between steatotic liver disease and liver cancer
  Mohammad Rahbari, Albert Gris-Oliver, Pierluigi Ramadori, David Aicher, Daniela Sia, Nisar P. Malek, Rohit Loomba, Ramon Bataller, Josep M. Llovet, Mathias Heikenwälder
  Nature Reviews Cancer.2026; 26(6): 415.     CrossRef
• Neutrophil polarization landscapes in HCC: From immunosuppressive niches to antitumor immunity resuscitation
  Jun Sun, Fan Yang, Yinyan Li, Shenglong Li, Jianbo Song
  Cancer Letters.2026; 651: 218527.     CrossRef
• Neutrophil extracellular traps: A central player in liver diseases
  Han Wang, Allan Tsung, Hongji Zhang
  Hepatology Communications.2026;[Epub]     CrossRef
• Lipopolysaccharide, arbiter of the gut–liver axis, modulates hepatic cell pathophysiology in alcoholism
  Ki M. Mak, Aditya C. Shekhar
  The Anatomical Record.2025; 308(3): 975.     CrossRef
• Could intratumoural microbiota be key to unlocking treatment responses in hepatocellular carcinoma?
  Kin Lam Yu, Sj Shen
  European Journal of Cancer.2025; 216: 115195.     CrossRef
• The dual role of neutrophils in sepsis-associated liver injury
  Lexin Fang, Yu Song, Jiangtao Chen, Yueping Ding
  Frontiers in Immunology.2025;[Epub]     CrossRef
• Roles of the gut microbiota in hepatocellular carcinoma: from the gut dysbiosis to the intratumoral microbiota
  Yiqin Wang, Yongqiang Li, Yong Lin, Chuangyu Cao, Dongcheng Chen, Xianguang Huang, Canhua Li, Haoming Xu, Huasheng Lai, Huiting Chen, Yongjian Zhou
  Cell Death Discovery.2025;[Epub]     CrossRef
• Neutrophil elastase binds at the central domain of extracellular Toll-like receptor 4: AI prediction, docking, and validation in disease model
  Azeem Ali, Leena Gaba, Sujata Jetley, Imran A. Khan, Prem Prakash
  Scientific Reports.2025;[Epub]     CrossRef
• Neutrophil extracellular traps (NETs) and NETosis in alcohol‐associated diseases: A systematic review
  Mohammed A. S. Khan, Byoung‐Joon Song, Xin Wang, Shams Iqbal, Gyongyi Szabo, Sulie L. Chang
  Alcohol, Clinical and Experimental Research.2025; 49(4): 697.     CrossRef
• Toll Like Receptors Promote High Glucose-Induced Vascular Endothelial Cell Dysfunction by Regulating Neutrophil Extracellular Traps Formation
  Shirou Wu, Yahui Chen, Xiuming Jin, Jiayun Yu, Xueping Chen, Ting Wan
  Inflammation.2025; 48(5): 3542.     CrossRef
• Regulatory role of gut microbiota in immunotherapy of hepatocellular carcinoma
  Jiajia Du, Yan Guan, Erlei Zhang
  Hepatology International.2025; 19(3): 507.     CrossRef
• Food additive β-caryophyllene mitigates alcoholic steatohepatitis by dual modulation of inflammation and lipid metabolism: a diet-based intervention strategy
  Jun-Liang Yang, Zhi-Hong Zhang, Xue-Li Jiang, Si-Qi Wang, Yan-Ling Wu, Ji-Xing Nan, Li-Hua Lian
  Food & Function.2025; 16(13): 5393.     CrossRef
• Dietary yeast extract prevents alcoholic liver disease in mice via correcting gut dysbiosis and improving intestinal barrier function
  Hao Han, Lei Tian, Yajing Dong, Yanyang Han, Xiaoman Wang, Qian Cheng, Haibo Zhang, Yan Zhang
  Food Science and Human Wellness.2025; 14(6): 9250146.     CrossRef
• Microbial Modulation of the Gut–Liver Axis in Autoimmune Liver Diseases
  Shihui Wei, Juan Lu
  Seminars in Liver Disease.2025; 45(04): 498.     CrossRef
• Gut Microbiota and the Gut-liver Axis in Hepatocellular Carcinoma: A Comprehensive Review of Pathogenesis and Therapeutic Strategies
  Satyam Yadav, Ranjeet Kumar
  Anti-Cancer Agents in Medicinal Chemistry.2025; 25(17): 1287.     CrossRef
• Co-fermentation of honeysuckle-Cassia seeds by Lactobacillus acidophilus and Bacillus subtilis: A new approach to attenuate alcohol-induced acute gastric mucosal damage and modulate immune response
  Mengtian Zhou, Xinran Cao, Huike Ji, Zhaoxue Liu, Hongyi Guo, Yingao Zhang, Yongqi Huang, Fang Wang, Meixia Pang, Ying Wei
  Food Research International.2025; 222: 117639.     CrossRef
• Neutrophil extracellular traps as therapeutics target in vascular aging
  Jie Mao, Shuang Wu, Zelin Yan, Guiping Huang, Yihua Yu
  Frontiers in Immunology.2025;[Epub]     CrossRef
• Gut microbial metabolites in cancer immunomodulation
  Hengshuo Liu, Xingyu Xiong, Weizhen Zhu, Sheng Wang, Weichao Huang, Guoqing Zhu, Hang Xu, Lu Yang
  Molecular Cancer.2025;[Epub]     CrossRef
• Unveiling the covert interaction between gut microbiota and neutrophils to drive colorectal cancer metastasis
  Peiliang Shen, Peng Cheng, Yanan Li, Gangfan Zong, Rui Deng, Cheng Qian, Yang Zhao, Zhonghong Wei, Yin Lu
  European Journal of Pharmacology.2024; 962: 176217.     CrossRef
• Toxoplasma gondii-induced neutrophil extracellular traps are relevant to glycolysis, TLR2, and TLR4 MAPK signaling pathway in goats
  Zha Jin, Qinqin Jin, Meiyi Chen, Wei Liu, Hongrong Hong, Yuqian Jiang, Xinxin Gao, Yuxiao Qian, Zedong Wang, Quan Liu, Zhengkai Wei
  Parasitology Research.2024;[Epub]     CrossRef
• γδ T Cells: A Game Changer in the Future of Hepatocellular Carcinoma Immunotherapy
  Stavros P. Papadakos, Konstantinos Arvanitakis, Ioanna E. Stergiou, Maria-Loukia Koutsompina, Georgios Germanidis, Stamatios Theocharis
  International Journal of Molecular Sciences.2024; 25(3): 1381.     CrossRef
• The causal correlation between gut microbiota abundance and pathogenesis of cervical cancer: a bidirectional mendelian randomization study
  Hua Yang
  Frontiers in Microbiology.2024;[Epub]     CrossRef
• Platelets in Alcohol-Associated Liver Disease: Interaction With Neutrophils
  Juan Wang, Xianda Wang, Haodong Peng, Zijian Dong, Suthat Liangpunsakul, Li Zuo, Hua Wang
  Cellular and Molecular Gastroenterology and Hepatology.2024; 18(1): 41.     CrossRef
• An integrated network pharmacology approach reveals that Ampelopsis grossedentata improves alcoholic liver disease via TLR4/NF-κB/MLKL pathway
  Ping Qiu, Ai Mi, Chunlan Hong, Shuo Huang, Qing Ma, Qihan Luo, Jiang Qiu, He Jiang, Yufan Chen, Fangming Chen, Honghao Yan, Jinkai Zhao, Yu Kong, Yu Du, Changyu Li, Desong Kong, Thomas Efferth, Dayong Lou
  Phytomedicine.2024; 132: 155658.     CrossRef
• Expansion of effector regulatory T cells in steroid responders of severe alcohol-associated hepatitis
  Min Woo Kang, Soon Kyu Lee, Eun Ji Jang, Jong Geun Park, Deok Hwa Seo, Ji Won Han, Jae Sung Yoo, Jung Hyun Kwon, Soon Woo Nam, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung
  Liver Transplantation.2024; 30(9): 877.     CrossRef
• Imaging and Therapy of Tumors Based on Neutrophil Extracellular Traps
  Yongwei Hao, Dalin Liu, Kaiyuan Wang, Qian Liu, Hongli Chen, Shenglu Ji, Dan Ding
  Small Science.2024;[Epub]     CrossRef
• Understanding gut dysbiosis for hepatocellular carcinoma diagnosis and treatment
  Jingjing Yu, Xiaoping Chen, Xiangliang Yang, Bixiang Zhang
  Trends in Endocrinology & Metabolism.2024; 35(11): 1006.     CrossRef
• Timing, initiation and function: An in-depth exploration of the interaction network among neutrophil extracellular traps related genes in acute pancreatitis
  Haoyu Zhang, Zheng Wang, Jie Li, Yuchen Jia, Fei Li
  International Immunopharmacology.2024; 141: 112923.     CrossRef
• Interaction between intratumoral microbiota and neutrophils influences tumor progression
  Mengyuan Hu
  American Journal of Clinical and Experimental Immunology.2024; 13(5): 233.     CrossRef
• Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models
  Xiao Hong, Shuo Huang, He Jiang, Qing Ma, Jiang Qiu, Qihan Luo, Chunlu Cao, Yiyang Xu, Fuzhe Chen, Yufan Chen, Chunfeng Sun, Haozhe Fu, Yiming Liu, Changyu Li, Fangming Chen, Ping Qiu
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• G-CSF exacerbates liver injury in a mouse model of autoimmune hepatitis
  Yi Shen, Yifeng Liu, Kexin Yu, Mengyi Shen, Li Yang
  Journal of Hepatology.2023; 79(1): e29.     CrossRef
• Structure and hepatoprotective activity of Usp10/NF-κB/Nrf2 pathway-related Morchella esculenta polysaccharide
  Shanshan Teng, Yongfeng Zhang, Xinghui Jin, Yanfeng Zhu, Lanzhou Li, Xiaowei Huang, Di Wang, Zhe Lin
  Carbohydrate Polymers.2023; 303: 120453.     CrossRef
• Neutrophil extracellular traps in tumor progression and immunotherapy
  Meina Yan, Yifeng Gu, Hongxia Sun, Qinghong Ge
  Frontiers in Immunology.2023;[Epub]     CrossRef
• The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks?
  Stavros P. Papadakos, Konstantinos Arvanitakis, Ioanna E. Stergiou, Vasileios Lekakis, Spyridon Davakis, Maria-Ioanna Christodoulou, Georgios Germanidis, Stamatios Theocharis
  Cancers.2023; 15(10): 2795.     CrossRef
• Loss of toll-like receptor 5 potentiates spontaneous hepatocarcinogenesis in farnesoid X receptor–deficient mice
  Rachel M. Golonka, Beng San Yeoh, Piu Saha, Amira Gohara, Ramakumar Tummala, Stanislaw Stepkowski, Amit K. Tiwari, Bina Joe, Frank J. Gonzalez, Andrew T. Gewirtz, Matam Vijay-Kumar
  Hepatology Communications.2023;[Epub]     CrossRef
• The role of neutrophil extracellular traps and proinflammatory damage-associated molecular patterns in idiopathic inflammatory myopathies
  Wenlan Ma, Jiarui Zhu, Ling Bai, Peipei Zhao, Feifei Li, Sigong Zhang
  Clinical and Experimental Immunology.2023; 213(2): 202.     CrossRef
• Fusobacterium nucleatum-triggered neutrophil extracellular traps facilitate colorectal carcinoma progression
  Xuehua Kong, Yu Zhang, Linwei Xiang, Yan You, Yaqian Duan, Yuqing Zhao, Shue Li, Rui Wu, Jiangbo Zhang, Lan Zhou, Liang Duan
  Journal of Experimental & Clinical Cancer Research.2023;[Epub]     CrossRef
• Advancements in the Alcohol-Associated Liver Disease Model
  Lin Zhu, Hai-Di Li, Jie-Jie Xu, Juan-Juan Li, Miao Cheng, Xiao-Ming Meng, Cheng Huang, Jun Li
  Biomolecules.2022; 12(8): 1035.     CrossRef
• Emerging Role of Neutrophil Extracellular Traps in Gastrointestinal Tumors: A Narrative Review
  Yujun Zhang, Jingjing Song, Yiwei Zhang, Ting Li, Jie Peng, Haonan Zhou, Zhen Zong
  International Journal of Molecular Sciences.2022; 24(1): 334.     CrossRef

Citations

Citations to this article as recorded by  

• Mutation of PXR phosphorylation motif at Ser347 disrupts lipid and bile acid homeostasis in diet-induced metabolic dysfunction–associated steatohepatitis in mice
  Veronia Basaly, Zakiyah R. Henry, Rulaiha E. Taylor, Bo Kong, Ill Yang, Anita Brinker, Zhenning Yang, Peihong Zhou, Laurie B. Joseph, Lauren Aleksunes, Brian Buckley, Masahiko Negishi, Grace L. Guo
  Drug Metabolism and Disposition.2026; 54(2): 100222.     CrossRef
• Analysis of Antimicrobial Peptide Expression Under Acute and Chronic Alcohol Exposure: A Cross-Sectional Study and a Systematic Review of the Literature
  Maura Rojas-Pirela, Cristian Herrera-Flores, Pilar Costa-Alba, Daniel Salete-Granado, María-Lourdes Aguilar, David Puertas-Miranda, Beatriz Cicuéndez, María-Ángeles Pérez-Nieto, Candy Pérez-Albornoz, Cintia Folgueira, Alfonso Mora, Guadalupe Sabio, Miguel
  International Journal of Molecular Sciences.2026; 27(4): 2026.     CrossRef
• Intermittent fasting ameliorates MAFLD by downregulating Lrg1: insights from bulk RNA sequencing and functional verification
  Huafeng Chen, Shilin Zhang, Wenqiang Xie, Jie Shen, Hua Liang
  Frontiers in Endocrinology.2026;[Epub]     CrossRef
• Inflammatory Adipokines and Potential Oxidative Stress-Related Mechanisms Linking MASLD with Subclinical Atherosclerosis Within CKM Syndrome: A Systematic Review and Meta-Analysis
  Cezara-Andreea Gerdanovics, Șoimița-Mihaela Suciu, Olga-Hilda Orășan, Ioana Para, Vladiana-Romina Turi, Adela-Sitar Tăut, Mircea-Vasile Milaciu, Mirela-Georgiana Perne, Teodora-Gabriela Alexescu, Lorena Ciumărnean, Alexandru Gerdanovics, Vlad-Dumitru Brat
  Antioxidants.2026; 15(6): 684.     CrossRef
• A diet-driven metabolic dysfunction-associated steatohepatitis (MASH) mouse model resembles the corresponding human disease
  Guilherme Ribeiro Romualdo, Letícia C. Valente, Gabriel P. Bacil, Luana Riechelmann-Casarin, Antônio R. B. da Fonseca, Miguel W. Fornes, Luís F. Barbisan
  Journal of Molecular Histology.2025;[Epub]     CrossRef
• Role of Neutrophils in Homeostasis and Diseases
  Xingyu Chang, Yulin Liu, Junjun Qiu, Keqin Hua
  MedComm.2025;[Epub]     CrossRef
• The Role of an Elevated Fibrosis‐4 Index in Neurocognitive Decline and Brain Volume Reduction in Older Adults With Metabolic Dysfunction‐Associated Steatotic Liver Disease
  Maiko Nagaoka, Katsuya Nagaoka, Naoto Kajitani, Kazuhiro Yoshiura, Yoko Yoshimaru, Takehisa Watanabe, Hiroko Setoyama, Noboru Fujise, Minoru Takebayashi, Yasuhito Tanaka
  Geriatrics & Gerontology International.2025; 25(12): 1903.     CrossRef
• Genetic and Molecular Profiling of PLIN5 and LCN2 in Hepatocellular Carcinoma: Implications for Diagnosis and Prognosis
  Mahsa Sadat Reypour, Bita Moudi, Massoud Houshmand, Seyyedeh Behnaz Motahari
  International Journal of Infection.2025;[Epub]     CrossRef
• Dynamic changes and clinical value of lipocalin 2 in liver diseases caused by microbial infections
  Feng Chen, Shan-Shan Wu, Chao Chen, Cheng Zhou
  World Journal of Hepatology.2024; 16(2): 177.     CrossRef
• Loss of SREBP-1c ameliorates iron-induced liver fibrosis by decreasing lipocalin-2
  Eun-Ho Lee, Jae-Ho Lee, Do-Young Kim, Young-Seung Lee, Yunju Jo, Tam Dao, Kyung Eun Kim, Dae-Kyu Song, Ji Hae Seo, Young-Kyo Seo, Je Kyung Seong, Changjong Moon, Eugene Han, Mi Kyung Kim, Seungwan Ryu, Minsang Shin, Gu Seob Roh, Hye Ra Jung, Timothy F. Os
  Experimental & Molecular Medicine.2024; 56(4): 1001.     CrossRef
• The relevance of intestinal barrier dysfunction, antimicrobial proteins and bacterial endotoxin in metabolic dysfunction‐associated steatotic liver disease
  Ina Bergheim, José María Moreno‐Navarrete
  European Journal of Clinical Investigation.2024;[Epub]     CrossRef
• Diagnostic and prognostic value of plasma lipocalin-2 levels in patients with metabolic dysfunction–associated steatotic liver disease
  Ahmed Mohamed ElGhandour, Nahla Mohamed Teama, Marwa Abdullah Kamal, Ehab Hassan Nashaat, Amani Mohamed Abdel Ghani, Ahmad Abbas Abdo
  Egyptian Liver Journal.2024;[Epub]     CrossRef
• Lipocalin-2 levels increase in plasma of non-alcoholic fatty liver disease patients with metabolic syndrome
  Hirdesh Chawla, Vivek Bhosale, Ravi Misra, Satyendra Kumar Sonkar, Neera Kohli, Naseem Jamal, Shobhit Raj Vimal, Banwari Dangi, Kavita Durgapal, Shail Singh, Mahendra Pal Singh Negi, Ashim Ghatak
  International Journal of Diabetes in Developing Countries.2023; 43(1): 105.     CrossRef
• Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets
  Liu Yang, Yawen Hao, Joost Boeckmans, Robim M. Rodrigues, Yong He
  Pharmacology & Therapeutics.2023; 243: 108353.     CrossRef
• Screening strategy for non-alcoholic fatty liver disease
  Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
  Clinical and Molecular Hepatology.2023; 29(Suppl): S103.     CrossRef
• Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
  Tina Reinson, Ryan M. Buchanan, Christopher D. Byrne
  Clinical and Molecular Hepatology.2023; 29(Suppl): S157.     CrossRef
• LCN2 contributes to the improvement of nonalcoholic steatohepatitis by 8-Cetylberberine
  Huan He, Xue Chai, Juan Li, Changsheng Li, Xinran Wu, Xiaoli Ye, Hang Ma, Xuegang Li
  Life Sciences.2023; 321: 121595.     CrossRef
• Lipocalin-2 Secreted by the Liver Regulates Neuronal Cell Function Through AKT-Dependent Signaling in Hepatic Encephalopathy Mouse Model
  Danbi Jo, Yoon Seok Jung, Juhyun Song
  Clinical Nutrition Research.2023; 12(2): 154.     CrossRef
• From NAFLD to HCC: Advances in noninvasive diagnosis
  Qinchen Xu, Maoxiao Feng, Yidan Ren, Xiaoyan Liu, Huiru Gao, Zigan Li, Xin Su, Qin Wang, Yunshan Wang
  Biomedicine & Pharmacotherapy.2023; 165: 115028.     CrossRef
• The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery
  Jiaqi Chen, Shihui Lei, Yueye Huang, Xiaojuan Zha, Lei Gu, Donglei Zhou, Jun Li, Feng Liu, Nannan Li, Lei Du, Xiu Huang, Ziwei Lin, Le Bu, Shen Qu
  Lipids in Health and Disease.2022;[Epub]     CrossRef
• Immune-related pathogenesis and therapeutic strategies of nonalcoholic steatohepatitis
  Ki Wung Chung, Ye Eun Cho, Seung-Jin Kim, Seonghwan Hwang
  Archives of Pharmacal Research.2022; 45(4): 229.     CrossRef
• Bioinformatics analysis reveals the changes of peroxisome proliferator-activated receptor (PPAR) pathway in the development of Marjolin ulcers
  Cheng Wang, Lin Cheng, Ying Zhang, Xiaozhuo Zhao, Huijun Zhang, Yuming Shen
  All Life.2022; 15(1): 960.     CrossRef
• A multi-omic landscape of steatosis-to-NASH progression
  Liping Xiang, Xiaoyan Li, Yunchen Luo, Bing Zhou, Yuejun Liu, Yao Li, Duojiao Wu, Lijing Jia, Pei-Wu Zhu, Ming-Hua Zheng, Hua Wang, Yan Lu
  Life Metabolism.2022; 1(3): 242.     CrossRef
• A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
  Marinela Krizanac, Paola Berenice Mass Sanchez, Ralf Weiskirchen, Anastasia Asimakopoulos
  International Journal of Molecular Sciences.2021; 22(6): 2865.     CrossRef
• Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis
  Seonghwan Hwang, Hwayoung Yun, Sungwon Moon, Ye Eun Cho, Bin Gao
  Frontiers in Endocrinology.2021;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Schwanger werden nach Mamma- oder Genitalkarzinom – Wann darf ich mich trauen?
  Julia Téoule, Karin Bundschu, Katharina Hancke
  Die Gynäkologie.2026; 59(2): 105.     CrossRef
• Therapeutic potential and pharmacological mechanisms of cannabinoids in alleviating chemotherapy-induced organ toxicity and adverse effects
  Bushra Zia, M.F. Nagoor Meeran, Charu Sharma, Sameer Mirza, Shreesh K. Ojha
  European Journal of Pharmacology.2026; 1017: 178646.     CrossRef
• Quantifying Functional Liver Volume Loss after CT-guided Percutaneous Thermal Ablation: A COVER-ALL Trial Post Hoc Analysis
  Noreen S. Siddiqi, Jessica Albuquerque, Iwan Paolucci, Yuan-Mao Lin, Caleb O’Connor, Antony Haddad, Aaron K. Jones, Jean-Nicholas Vauthey, Kristy K. Brock, Bruno C. Odisio
  Radiology: Imaging Cancer.2026;[Epub]     CrossRef
• Infiltrative liver conditions: a pictorial review of malignant and benign entities
  Jordan Zheng Ting Sim, Nicole Kessa Wee, Hsien Min Low
  Singapore Medical Journal.2026; 67(3): 184.     CrossRef
• Hepatoprotective effects of Ulva fasciata against cisplatin-induced liver injury in rats: GC–MS-based identification, In Silico ADME profiling, and molecular docking analysis of bioactive compounds
  Nida Sohail, Muhammad Bilal Azmi, Hafiza Farhat, Kanwal Khan, Faizah Urooj, Bilal Ahmad Ghalloo, Shamim Akhtar Qureshi
  Computers in Biology and Medicine.2026; 213: 111804.     CrossRef
• Hepatoprotective effects of phytochemicals and plant extracts against chemotherapy-induced liver damage in animal models: a systematic review
  Jignesh Prajapati, Narendra Bhatt, Rakesh Rawal
  Archives of Toxicology.2025; 99(3): 887.     CrossRef
• Negative impact of chemotherapy on kinetic growth rate of the future liver remnant if applied following PVE or ALPPS
  Klara Welcker, Martin A. Schneider, Tim Reese, Andrea Ehrenfeld, Hauke Weilert, Axel Stang, Peter Wohlmuth, Mia-Maria Warnke, Carolin Reiner, Thomas von Hahn, Karl J. Oldhafer, Andreas H. Mahnken, Roland Brüning, Gregory Tiao
  PLOS ONE.2025; 20(3): e0307937.     CrossRef
• Pregnancy after cancer: FIGO Best practice advice
  Cynthia Maxwell, Sumaiya Adam, Lina Bergman, Surabhi Nanda, Valerie Tiempo Guinto, Noa Popovits‐Hadari, Maisah Al‐Bakri, Ifeyinwa Nwokoro, Fionnuala McAuliffe, Inge Peters, Catherine Nelson‐Piercy, Frederic Amant, Melanie Nana, Graeme Smith, Jonathan Bere
  International Journal of Gynecology & Obstetrics.2025; 169(3): 1119.     CrossRef
• Coagulation profiles of breast cancer patients attending at cancer treatment centres in Northwest Ethiopia 2023: a comparative cross-sectional study
  Sisay Ayana, Melak Aynalem, Tiruneh Adane, Elias Shiferaw
  Scientific Reports.2025;[Epub]     CrossRef
• Imaging findings of post-chemotherapy non-metastatic hepatic parenchymal changes
  San Yu Leung, Wing Tung Chiu, Matthew Ka Ki Law, Ho Ching Amy Wong, Alta Lai, Yiu Shiobhon Luk
  Journal of Clinical Imaging Science.2025; 15: 24.     CrossRef
• Repurposing edaravone in oncology: Bridging antioxidant defense and immune modulation
  Sara I. Ibrahim, Dana M. Zaher, Fatema A. Hersi, Alaa O. Hamouda, Manar A. Al Hindawi, Hany A. Omar
  International Immunopharmacology.2025; 164: 115413.     CrossRef
• Proteomic profiling reveals the molecular signatures of chemotherapy-induced human ovarian damage
  Johanne Grosbois, Xavier Bisteau, Virginie Imbault, Louise Conrard, Margherita Condorelli, Necati Findikli, Pascale Lybaert, Isabelle Demeestere
  Human Reproduction.2025; 40(12): 2395.     CrossRef
• Recent advances in stimuli-responsive tailored nanogels for cancer therapy; from bench to personalized treatment
  Prinsy Rana, Charan Singh, Ajeet Kaushik, Shakir Saleem, Arun Kumar
  Journal of Materials Chemistry B.2024; 12(2): 382.     CrossRef
• Efficacy and Safety of Metronomic Capecitabine in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
  Nandini Gupta, Neelkant Verma, Bhoomika Patel
  Journal of Gastrointestinal Cancer.2024; 55(4): 1485.     CrossRef
• Efficacy of concomitant therapy with ademetionine in antitumor drug therapy: A review
  Nikolai A. Ognerubov
  Consilium Medicum.2024; 26(6): 351.     CrossRef
• CEUS compared with CECT, MRI, and FDG-PET/CT for diagnosing CRC liver metastases: a diagnostic test accuracy systematic review and meta-analysis
  Martin Lund, Thomas A. Bjerre, Henning Grønbæk, Frank V. Mortensen, Per Kragh Andersen
  Expert Review of Gastroenterology & Hepatology.2024; 18(9): 541.     CrossRef
• Application of Nanoparticles in the Diagnosis and Treatment of Colorectal Cancer
  Qiuyu Song, Yifeng Zheng, Guoqiang Zhong, Shanping Wang, Chengcheng He, Mingsong Li
  Anti-Cancer Agents in Medicinal Chemistry.2024; 24(18): 1305.     CrossRef
• Imaging of body complications in pediatric oncology: a review of the literature and our experience
  Valentina Cariello, Patrizia Lombardo, Diana Baldari, Maria Cristina Smaldone, Paolo Pizzicato, Antonio Rossi, Luca Brunese, Giuseppe Paviglianiti, Maria Chiara Brunese, Rocco Minelli, Eugenio Rossi
  Journal of Medical Imaging and Interventional Radiology.2024;[Epub]     CrossRef
• MRI findings of newly present benign focal hepatic observations following chemotherapy: distinct features in early- and late-term follow-up
  Yiqi Wang, Siyue Mao, Runqian Huang, Sheng Li, Rongzhen Luo, Jingxian Shen
  European Radiology.2024; 35(5): 2783.     CrossRef
• Liver Dysfunction After Use of Nathanson Retractor During Laparoscopic Gastrectomy for Gastric Cancer
  Serdar Culcu, Selim Tamam, Cem Azili, Siyar Ersoz, Baris Morkavuk, Ali Ekrem Unal, Salim Demirci
  Journal of Laparoendoscopic & Advanced Surgical Techniques.2023; 33(2): 205.     CrossRef
• Concomitant Sub-Chronic Administration of Small-Size Gold Nanoparticles Aggravates Doxorubicin-Induced Liver Oxidative and Inflammatory Damage, Hyperlipidemia, and Hepatic Steatosis
  Ghedeir M. Alshammari, Mohamed Anwar Abdelhalim, Mohammed S. Al-Ayed, Laila Naif Al-Harbi, Mohammed Abdo Yahya
  Molecules.2023; 28(2): 796.     CrossRef
• Therapeutic options in hepatocellular carcinoma: a comprehensive review
  Diwakar Suresh, Akshatha N. Srinivas, Akila Prashant, Kuzhuvelil B. Harikumar, Divya P. Kumar
  Clinical and Experimental Medicine.2023; 23(6): 1901.     CrossRef
• Amelioration of cyclophosphamide-induced DNA damage, oxidative stress, and hepato- and neurotoxicity by Piper longum extract in rats: The role of γH2AX and 8-OHdG
  Vaishali Yadav, Anuja Krishnan, Sultan Zahiruddin, Sayeed Ahmad, Divya Vohora
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• Ring Enhancement in Non-Neoplastic Breast Tissue on MRI During Neoadjuvant Chemotherapy for Breast Cancer: Incidence and Clinical Implications
  Jiyun Oh, Boo-Kyung Han, Eun Y. Ko, Eun S. Ko, Ji S. Choi, Haejung Kim, Yeon H. Park, Ji-Yeon Kim
  Academic Radiology.2023; 30(12): 2931.     CrossRef
• The Effect of Metformin on Chemotherapy-Induced Toxicities in Non-diabetic Breast Cancer Patients: A Randomised Controlled Study
  Manar A. Serageldin, Amira B. Kassem, Yasser El-Kerm, Maged W. Helmy, Mahmoud M. El-Mas, Noha A. El-Bassiouny
  Drug Safety.2023; 46(6): 587.     CrossRef
• The role of ursodeoxycholic acid in the treatment of chemotherapy induced hepatotoxicity in the maintenance treatment of children with acute leukemia
  Özlem TERZİ, Ali AYÇİÇEK, Duygu YILDIRGAN, Hüseyin Avni SOLGUN, Sibel TEKGÜNDÜZ, Cengiz BAYRAM
  Family Practice and Palliative Care.2023; 8(4): 101.     CrossRef
• Stereological Estimation and Zonal Distribution of the Hepatotoxic Effects of Doxorubicin on the Female Albino Rat (Rattus Norvegicus)
  Khulud Nurani, Anne Pulei, Beda Olabu, Jeremiah Munguti, Talha Chaudhry, Vincent Kipkorir
  International Journal of Medical Students.2023; 11(3): 184.     CrossRef
• Clinical implications of chemotherapeutic agent organ toxicity on perioperative care
  Justin Zeien, Wendy Qiu, Mason Triay, Hemangini A. Dhaibar, Diana Cruz-Topete, Elyse M. Cornett, Ivan Urits, Omar Viswanath, Alan David Kaye
  Biomedicine & Pharmacotherapy.2022; 146: 112503.     CrossRef
• Simple fabrication of multifunctional hyperbranched copolymer based on l-lysine and citric acid for co-delivery of anticancer drugs to breast cancer cells
  Robab Aslani, Hassan Namazi
  Reactive and Functional Polymers.2022; 170: 105101.     CrossRef
• Liver Surgery: Important Considerations for Pre- and Postoperative Imaging
  Luisa Leitão de Faria, George Felipe Darce, André Leopoldino Bordini, Paulo Herman, Vagner Birk Jeismann, Iraí Santana de Oliveira, Cinthia D. Ortega, Manoel de Souza Rocha
  RadioGraphics.2022; 42(3): 722.     CrossRef
• Cancer Treatment by Laser and Electrochemical Therapy Combined with Magnetic Nanoparticles as Potent Therapy Against Ehrlich Ascites Carcinoma
  Sahar E. Abo-Neima, Emad M. Elsehly
  BioNanoScience.2022; 12(3): 851.     CrossRef
• Evaluation of liver function tests to identify hepatotoxicity among acute lymphoblastic leukemia patients who are receiving chemotherapy induction
  Ayal Tsegaye Mekonnen, Temesgen Gebeyehu Wondmeneh
  Scientific Reports.2022;[Epub]     CrossRef
• Prognostic Factors for Overall Survival in Patients with HCV-Related HCC Undergoing Molecular Targeted Therapies: Beyond a Sustained Virological Response
  Yasunori Minami, Tomoko Aoki, Hirokazu Chishina, Masahiro Takita, Satoru Hagiwara, Hiroshi Ida, Kazuomi Ueshima, Naoshi Nishida, Masatoshi Kudo
  Cancers.2022; 14(19): 4850.     CrossRef
• The Evidence Surrounding Non-Alcoholic Fatty Liver Disease in Individuals with Cancer: A Systematic Literature Review
  Elena S. George, Surbhi Sood, Nicole Kiss, Robin M. Daly, Amanda J. Nicoll, Stuart K. Roberts, Brenton J. Baguley
  Current Oncology.2022; 30(1): 48.     CrossRef
• In Vivo Photodynamic Therapy With a Lipophilic Zinc(II) Phthalocyanine Inhibits Colorectal Cancer and Induces a Th1/CD8 Antitumor Immune Response
  Nicolás Chiarante, Maite Duhalde Vega, Federico Valli, Elsa Zotta, Hellen Daghero, Tatiana Basika, Mariela Bollati‐Fogolin, María C. García Vior, Julieta Marino, Leonor P. Roguin
  Lasers in Surgery and Medicine.2021; 53(3): 344.     CrossRef
• Hepatic perfusional changes on CT and MRI: a radiology primer
  Dane Gunter, Shaista Riaz, Ehsan A. Haider, Ryan Rebello, Michael N. Patlas, Abdullah Alabousi
  Abdominal Radiology.2021; 46(1): 179.     CrossRef
• Abdominal immune-related adverse events: detection on ultrasonography, CT, MRI and 18F-Fluorodeoxyglucose positron emission tomography
  Mark A Anderson, Vikram Kurra, William Bradley, Aoife Kilcoyne, Amirkasra Mojtahed, Susanna I Lee
  The British Journal of Radiology.2021;[Epub]     CrossRef
• Muscle-Invasive Bladder Cancer in Patients with Liver Cirrhosis: A Review of Pertinent Considerations
  John Kim, Harkanwal Randhawa, David Sands, Shahid Lambe, Marco Puglia, Pablo E. Serrano, Jehonathan H. Pinthus
  Bladder Cancer.2021; 7(3): 261.     CrossRef
• Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System
  Taurean Brown, DeLawrence Sykes, Antiño R. Allen
  Biomedicines.2021; 9(2): 189.     CrossRef
• Preclinical Toxicity and Safety of MM-129—First-in-Class BTK/PD-L1 Inhibitor as a Potential Candidate against Colon Cancer
  Justyna Magdalena Hermanowicz, Bartlomiej Kalaska, Krystyna Pawlak, Beata Sieklucka, Joanna Miklosz, Mariusz Mojzych, Dariusz Pawlak
  Pharmaceutics.2021; 13(8): 1222.     CrossRef
• Berberine—A potent chemosensitizer and chemoprotector to conventional cancer therapies
  Nalini Devarajan, Selvaraj Jayaraman, Jaideep Mahendra, Purushothaman Venkatratnam, Ponnulakshmi Rajagopal, Hema Palaniappan, Senthil Kumar Ganesan
  Phytotherapy Research.2021; 35(6): 3059.     CrossRef
• Animal models of chemotherapy-induced cognitive decline in preclinical drug development
  Jeena John, Manas Kinra, Jayesh Mudgal, G. L. Viswanatha, K. Nandakumar
  Psychopharmacology.2021; 238(11): 3025.     CrossRef
• Imaging of chemotherapy-induced liver toxicity: an illustrated overview
  Giovanni Brondani Torri, Matheus Dorigatti Soldatelli, Gustavo Felipe Luersen, Caroline Lorenzoni Almeida Ghezzi
  Hepatic Oncology.2021;[Epub]     CrossRef
• Hydrazone conjugated and DOX loaded PEGylated-Fe3O4 mesoporous magnetic nanoclusters (MNCs): hyperthermia and in vitro chemotherapy
  Ahmaduddin Khan, Niroj Kumar Sahu
  New Journal of Chemistry.2021; 45(46): 21646.     CrossRef
• Imaging of the chemotherapy-induced hepatic damage: Yellow liver, blue liver, and pseudocirrhosis
  Linda Calistri, Vieri Rastrelli, Cosimo Nardi, Davide Maraghelli, Sofia Vidali, Michele Pietragalla, Stefano Colagrande
  World Journal of Gastroenterology.2021; 27(46): 7866.     CrossRef
• Cordyline fruticosa(L.) A. Chev. leaves: isolation, HPLC/MS profiling and evaluation of nephroprotective and hepatoprotective activities supported by molecular docking
  Mona A. Raslan, Rehab F. Taher, Ahmed A. Al-Karmalawy, Dalia El-Ebeedy, Angham G. Metwaly, Nourhan M. Elkateeb, Aml Ghanem, Reem A. Elghaish, Ahmed I. Abd El Maksoud
  New Journal of Chemistry.2021; 45(47): 22216.     CrossRef
• Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report
  Tomohito Shinoda, Toshiyuki Tanahashi, Takuji Sakuratani, Masato Ota, Seito Fujibayashi, Shunya Kiriyama, Keita Matsumoto, Kazunori Yawata, Yoshiyuki Sasaki, Shinji Osada, Makoto Yamada
  Molecular and Clinical Oncology.2021;[Epub]     CrossRef
• The antioxidant and anticancer potential of Ricinus communis L. essential oil nanoemulsions
  Asma Javanshir, Ehsan Karimi, Atieh Darchini Maragheh, Masoud Homayouni Tabrizi
  Journal of Food Measurement and Characterization.2020; 14(3): 1356.     CrossRef
• Citrus aurantium L. bloom essential oil nanoemulsion: Synthesis, characterization, cytotoxicity, and its potential health impacts on mice
  Somayeh Navaei Shoorvarzi, Farzaneh Shahraki, Negin Shafaei, Ehsan Karimi, Ehsan Oskoueian
  Journal of Food Biochemistry.2020;[Epub]     CrossRef
• Effect of Chemotherapy on Fatty Liver Occurrence in Breast and Gastrointestinal Cancer Patients: A Case-Controlled Study
  Payam Izadpanahi, Mahyar Mohammadifard, Tahmine Tavakoli, Najmeh Abbasi, Seyed Alireza Javadinia
  Hepatitis Monthly.2020;[Epub]     CrossRef
• Other types of diffuse liver disease: is there a way to do it?
  Hilton Leao Filho, Camila Vilela de Oliveira, Natally Horvat
  Abdominal Radiology.2020; 45(11): 3425.     CrossRef
• New in vitro highly cytotoxic platinum and palladium cyanoximates with minimal side effects in vivo
  Stephanie D. Dannen, Lauren Cornelison, Paul Durham, John E. Morley, Kiana Shahverdi, Junwei Du, Haiying Zhou, Leland C. Sudlow, Daniel Hunter, Matthew D. Wood, Mikhail Y. Berezin, Nikolay Gerasimchuk
  Journal of Inorganic Biochemistry.2020; 208: 111082.     CrossRef
• Contrast-enhanced ultrasound compared with computed tomography, magnetic resonance imaging, and positron emission tomography-computed tomography for diagnosing liver metastases in people with newly diagnosed colorectal cancer
  Martin Lund, Tin Nadarevic, Thomas Abramovitz Bjerre, Henning Grønbaek, Frank Mortensen, Per Kragh Andersen
  Cochrane Database of Systematic Reviews.2020;[Epub]     CrossRef
• Ethanolic Leaf Extract of Ocimum gratissimum Abrogates Methotrexate-induced Liver Injury in Albino Rats
  Elias Adikwu, Bonsome Bokolo, Othuke Bensandy Odeghe
  Asian Journal of Biological Sciences.2020; 13(2): 201.     CrossRef
• Transitional Cell Carcinoma and Pseudocirrhosis— A Case Report and Review of the Literature
  Gilad Borisovsky, Daniel A. Goldstein, Noa Eliakim-Raz, Shlomit R. Tamir
  Journal of Gastrointestinal and Abdominal Radiology.2020; 3(S 01): S73.     CrossRef
• Diagnostic imaging of a mass-shape hepatic steatosis in a dog treated with chemotherapy
  N Lee, J Seo, J Kim, J Yoon
  Veterinární medicína.2020; 65(5): 221.     CrossRef
• A New Model for MR Evaluation of Liver Function with Gadoxetic Acid, Including Both Uptake and Excretion
  Daniel Truhn, Christiane K. Kuhl, Alexander Ciritsis, Alexandra Barabasch, Nils A. Kraemer
  European Radiology.2019; 29(1): 383.     CrossRef
• Toxicokinetics and Biliary Excretion of N-Nitrosodiethylamine in Rat Supplemented with Low and High Dietary Proteins
  S. E. Kuyooro, J. K. Akintunde, F. C. Okekearu, E. N. Maduagwu
  Journal of Dietary Supplements.2019; 16(5): 506.     CrossRef
• Quantitative magnetic resonance imaging evaluation of hepatic fat content with iron deposition: will it be disturbed?
  Qian Wang, Feng Ye, Peiqing Ma, Feng Chen, Yiqun Che, Xinming Zhao, Li Yang
  Journal of International Medical Research.2019; 47(5): 1958.     CrossRef
• An imaging-based review of systemic therapies and associated toxicities in metastatic pancreatic cancer as per the 2018 ASCO guidelines: what every radiologist should know
  Daniel A. Smith, Bhanusupriya Somarouthu, Nikhil H. Ramaiya
  Abdominal Radiology.2019; 44(6): 2182.     CrossRef
• Imatinib-induced hepatitis treated by corticosteroids in a patient with metastatic gastrointestinal stromal tumor
  Min Kyu Kang, Heon Ju Lee, Joon Hyuk Choi
  Yeungnam University Journal of Medicine.2019; 36(2): 155.     CrossRef
• Clinical features of pseudocirrhosis in metastatic breast cancer
  Caspian Oliai, Michael L. Douek, Caelainn Rhoane, Abhishek Bhutada, Phillip S. Ge, Bruce A. Runyon, Xiaoyan Wang, Sara A. Hurvitz
  Breast Cancer Research and Treatment.2019; 177(2): 409.     CrossRef
• CT and MR imaging of chemotherapy-induced hepatopathy
  Federica Vernuccio, Marco Dioguardi Burgio, Filippo Barbiera, Silvestro Cusmà, Giuseppe Badalamenti, Massimo Midiri, Valérie Vilgrain, Giuseppe Brancatelli
  Abdominal Radiology.2019; 44(10): 3312.     CrossRef
• Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer
  Kaat De Clercq, Feifan Xie, Olivier De Wever, Benedicte Descamps, Anne Hoorens, An Vermeulen, Wim Ceelen, Chris Vervaet
  Scientific Reports.2019;[Epub]     CrossRef
• Hepatic changes after treatment with oxaliplatin
  Leila Pereira Tenório, Michelle Ferraz Oliveira Miranda, Marcony Queiroz Andrade, Marcelo Antônio Nobrega Araujo
  Radiologia Brasileira.2019; 52(5): 343.     CrossRef
• Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant Tumors
  Nirmitha I. Herath, Nathalie Berthault, Sylvain Thierry, Wael Jdey, Marie-Christine Lienafa, Françoise Bono, Patricia Noguiez-Hellin, Jian-Sheng Sun, Marie Dutreix
  Frontiers in Oncology.2019;[Epub]     CrossRef
• Semicarbazide-sensitive amine oxidase activity levels in patients with acute lymphoblastic leukemia after cytotoxic chemotherapy
  Shatha Abdul Wadood AL‑Shammaree
  Beni-Suef University Journal of Basic and Applied Sciences.2018; 7(4): 683.     CrossRef
• IDEAL-IQ in an oncologic population: meeting the challenge of concomitant liver fat and liver iron
  Sarah Eskreis-Winkler, Giuseppe Corrias, Serena Monti, Junting Zheng, Marinela Capanu, Simone Krebs, Maggie Fung, Scott Reeder, Lorenzo Mannelli
  Cancer Imaging.2018;[Epub]     CrossRef
• 18F-FDG PET/CT in Local Ablative Therapies: A Systematic Review
  Erik H.J.G. Aarntzen, Linda Heijmen, Wim J.G. Oyen
  Journal of Nuclear Medicine.2018; 59(4): 551.     CrossRef
• Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: Radio-pathological correlation
  Sophie Cayet, Jeremy Pasco, Fanny Dujardin, Marie Besson, Isabelle Orain, Anne De Muret, Elodie Miquelestorena-Standley, Julien Thiery, Thibaud Genet, Anne-Gwenn Le Bayon
  European Journal of Radiology.2017; 94: 180.     CrossRef
• The Utilization of the Immune System in Lung Cancer Treatment: Beyond Chemotherapy
  Carmen Chan, Stephen Tsui, Bernard Law, Winnie So, Fiona Tang, Cho-Lee Wong
  International Journal of Molecular Sciences.2016; 17(3): 286.     CrossRef
• Pseudocirrhosis in Gastric Cancer with Diffuse Liver Metastases after a Dramatic Response to Chemotherapy
  Seiichiro Mitani, Shigenori Kadowaki, Hiroya Taniguchi, Hisanori Muto, Kei Muro
  Case Reports in Oncology.2016; 9(1): 106.     CrossRef
• Cancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective
  Danny Ngo, Jemianne Bautista Jia, Christopher S. Green, Anjalie T. Gulati, Chandana Lall
  Insights into Imaging.2015; 6(6): 665.     CrossRef

Citations

Citations to this article as recorded by  

• Exercise-Based Interventions for Metabolic Dysfunction–Associated Fatty Liver Disease: An Umbrella Review of Systematic Reviews and Meta-Analyses
  Xinjuan Huang, Ruoling Yu, Manjie Guo, Xinyun Tan, Yuanqin Xia, Huihui Zou, Xuelian Liu, Chunxiang Qin
  Nutrition Reviews.2026; 84(7): 1418.     CrossRef
• The association between serum pinenes and non-alcoholic fatty liver disease based on the NHANES 2013–2014
  Tuo Xiao, Xue Xing, Lulu Sun, Jin Shang
  Ecotoxicology and Environmental Safety.2025; 302: 118712.     CrossRef
• Exploring public interest in gut microbiome dysbiosis, NAFLD, and probiotics using Google Trends
  Salvatore Pezzino, Maria Sofia, Chiara Mazzone, Giorgia Litrico, Marcello Agosta, Gaetano La Greca, Saverio Latteri
  Scientific Reports.2024;[Epub]     CrossRef
• Metabolic dysfunction-associated fatty liver disease increases the risk of type 2 diabetes mellitus in young Korean adults
  Junchul Ha, Oak-Kee Hong, Kyungdo Han, Hyuk-Sang Kwon
  Diabetes Research and Clinical Practice.2024; 212: 111584.     CrossRef
• Genome-wide association study of metabolic dysfunction-associated fatty liver disease in a Korean population
  Young Lee, Eun Ju Cho, Eun Kyung Choe, Min-Sun Kwak, Jong In Yang, Seung-Won Oh, Jeong Yoon Yim, Goh Eun Chung
  Scientific Reports.2024;[Epub]     CrossRef
• Fatty Liver and Risk of Head and Neck Cancer in Type 2 Diabetes Mellitus: A Nationwide Cohort Study
  Junhee Park, Kyungdo Han, Seung Woo Lee, Yeong Jeong Jeon, Sang-Man Jin, Wonyoung Jung, Yoon Kyoung So, Sang Duk Hong, Dong Wook Shin
  Cancers.2023; 15(4): 1209.     CrossRef
• Occurrence of Liver Cancer in People without Traditional Risk Factors
  Junho Choi, Joohyun Park, Jae Kwang Lee, Kyunghee Cho
  Korean Journal of Clinical Geriatrics.2023; 24(1): 41.     CrossRef
• Protective effect of chlorophyll-removed ethanol extract of Lycium barbarum leaves against non-alcoholic fatty liver disease
  Hansol Lee, Eun Young Bae, Kyung Ah Kim, Sun Yung Ly
  Journal of Nutrition and Health.2023; 56(2): 123.     CrossRef
• Associations of physical activity domains and muscle strength exercise with non-alcoholic fatty liver disease: a nation-wide cohort study
  Yewan Park, Dong Hyun Sinn, Kyunga Kim, Geum-Youn Gwak
  Scientific Reports.2023;[Epub]     CrossRef
• New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut–Liver–Heart Crosstalk
  Keungmo Yang, Myeongjun Song
  Nutrients.2023; 15(18): 3970.     CrossRef
• Neck Circumference as a Predictor of Insulin Resistance in People with Non-alcoholic Fatty Liver Disease
  Da-Hye Son, Jee Hye Han, Jun-Hyuk Lee
  Journal of Obesity & Metabolic Syndrome.2023; 32(3): 214.     CrossRef
• Genome‐wide association of individual vulnerability with alcohol‐associated liver disease: A Korean genome and epidemiology study
  Kwang Yoon Kim, Jung Oh Kim, Young‐Sang Kim, Ja‐Eun Choi, Jae‐Min Park, Kunhee Han, Da‐Hyun Park, Yon Chul Park, Bom Taeck Kim, Kyung‐Won Hong
  Hepatology.2022; 75(2): 391.     CrossRef
• Association between serum uric acid level and non-alcoholic fatty liver disease in Koreans
  Huiyul Park, Kye-Yeung Park, Minki Kim, Hoon-Ki Park, Hwan-Sik Hwang
  Asian Biomedicine.2022; 16(1): 15.     CrossRef
• Non-alcoholic/Metabolic-Associated Fatty Liver Disease and Helicobacter pylori Additively Increase the Risk of Arterial Stiffness
  Ji Min Choi, Hyo Eun Park, Yoo Min Han, Jooyoung Lee, Heesun Lee, Su Jin Chung, Seon Hee Lim, Jeong Yoon Yim, Goh Eun Chung
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Association between non‐alcoholic fatty liver disease and the risk of dementia: A nationwide cohort study
  Gi‐Ae Kim, Chi Hyuk Oh, Jung Wook Kim, Su Jin Jeong, In‐Hwan Oh, Jin San Lee, Key‐Chung Park, Jae‐Jun Shim
  Liver International.2022; 42(5): 1027.     CrossRef
• Effect of intensive weight-loss intervention on metabolic, ultrasound and anthropometric parameters among patients with obesity and non-alcoholic fatty liver disease: an RCT
  Charu Arora, Anita Malhotra, Piyush Ranjan, Vishwajeet Singh, Namrata Singh, Shalimar, S. N. Dwivedi, Naval K. Vikram
  European Journal of Clinical Nutrition.2022; 76(9): 1332.     CrossRef
• Association between severe hepatic steatosis examined by Fibroscan and the risk of high-risk colorectal neoplasia
  Kwang Woo Kim, Hyoun Woo Kang, Hosun Yoo, Yukyung Jun, Hyun Jung Lee, Jong Pil Im, Ji Won Kim, Joo Sung Kim, Seong-Joon Koh, Yong Jin Jung, Atsushi Hosui
  PLOS ONE.2022; 17(12): e0279242.     CrossRef
• Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function
  Ji Taek Hong, Min-Jung Lee, Sang Jun Yoon, Seok Pyo Shin, Chang Seok Bang, Gwang Ho Baik, Dong Joon Kim, Gi Soo Youn, Min Jea Shin, Young Lim Ham, Ki Tae Suk, Bong-Soo Kim
  Journal of Ginseng Research.2021; 45(2): 316.     CrossRef
• Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events
  Joo Hyun Oh, Myung Ji Goh, Yewan Park, Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik
  Digestive Diseases and Sciences.2021; 66(8): 2816.     CrossRef
• The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation‐wide Cohort Study
  Yewan Park, Dong Hyun Sinn, Joo Hyun Oh, Myung Ji Goh, Kyunga Kim, Wonseok Kang, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Geum‐Youn Gwak
  Hepatology.2021; 74(6): 2988.     CrossRef
• Relationship between Muscle Mass and Non-Alcoholic Fatty Liver Disease
  Jun-Hyuk Lee, Hye-Sun Lee, Byoung-Kwon Lee, Yu-Jin Kwon, Ji-Won Lee
  Biology.2021; 10(2): 122.     CrossRef
• Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes Mellitus
  Lung-Wen Tsai, Yi-Hsiang Lu, Rajni Dubey, Jeng-Fong Chiou, Ilias Migdalis
  Journal of Diabetes Research.2021; 2021: 1.     CrossRef
• Cholecystectomy as a risk factor for metabolic dysfunction-associated fatty liver disease: unveiling the metabolic and chronobiologic clues behind the bile acid enterohepatic circulation
  Li Qi, Wanlin Dai, Jing Kong, Yu Tian, Yongsheng Chen
  Journal of Physiology and Biochemistry.2021; 77(4): 497.     CrossRef
• Development and initial validation of the nonalcoholic fatty liver disease self‐management questionnaire
  Oh Young Kwon, Yeonsoo Jang, Ji Yea Lee, Seung Up Kim, Sang Hoon Ahn
  Research in Nursing & Health.2021; 44(5): 844.     CrossRef
• Nutritional Approach Targeting Gut Microbiota in NAFLD—To Date
  Małgorzata Moszak, Monika Szulińska, Marta Walczak-Gałęzewska, Paweł Bogdański
  International Journal of Environmental Research and Public Health.2021; 18(4): 1616.     CrossRef
• Dairy protein intake is inversely related to development of non-alcoholic fatty liver disease
  Jun-Hyuk Lee, Hye Sun Lee, Sang Bong Ahn, Yu-Jin Kwon
  Clinical Nutrition.2021; 40(10): 5252.     CrossRef
• Nonalcoholic fatty liver disease increases the risk of diabetes in young adults: A nationwide population-based study in Korea
  Goh Eun Chung, Eun Ju Cho, Ji Won Yoon, Jeong-Ju Yoo, Young Chang, Yuri Cho, Sang-Hyun Park, Kyungdo Han, Dong Wook Shin, Su Jong Yu
  Metabolism.2021; 123: 154866.     CrossRef
• Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease
  Dong Hyun Sinn, Danbee Kang, Soo Jin Cho, Seung Woon Paik, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
  European Journal of Gastroenterology & Hepatology.2021; 33(1S): e529.     CrossRef
• NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea
  Jiyoon Park, Eunice Yewon Lee, Jie Li, Mi Jung Jun, Eileen Yoon, Sang Bong Ahn, Chuanli Liu, Hongli Yang, Fajuan Rui, Biyao Zou, Linda Henry, Dong Hyun Lee, Dae Won Jun, Ramsey C. Cheung, Mindie H. Nguyen
  Digestive Diseases.2021; 39(6): 634.     CrossRef
• SYSTEMATIC REVIEW WITH COMPARATIVE ANALYSIS OF RECOMMENDATIONS FOR THE DIAGNOSIS OF NONALCOHOLIC FATTY LIVER DISEASE
  N.A. TOKTOGULOVA
  AVICENNA BULLETIN.2021; 23(1): 107.     CrossRef
• Association between advanced fibrosis in fatty liver disease and overall mortality based on body fat distribution
  Goh Eun Chung, Nam Ju Heo, Donghee Kim, Min‐Sun Kwak, Jeong Yoon Yim, Joo Sung Kim, Aijaz Ahmed
  Journal of Gastroenterology and Hepatology.2020; 35(1): 90.     CrossRef
• Non‐alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study
  Dong Hyun Sinn, Danbee Kang, Yoosoo Chang, Seungho Ryu, Soo Jin Cho, Seung Woon Paik, Young Bin Song, Roberto Pastor‐Barriuso, Eliseo Guallar, Juhee Cho, Geum‐Youn Gwak
  Journal of Gastroenterology and Hepatology.2020; 35(5): 833.     CrossRef
• Modelling NAFLD disease burden in four Asian regions—2019‐2030
  Chris Estes, Henry L. Y. Chan, Rong N. Chien, Wan‐Long Chuang, James Fung, George Boon-Bee Goh, Tsung H. Hu, Jee‐Fu Huang, Byoung K. Jang, Dae W. Jun, Jia H. Kao, Jin‐Woo Lee, Han‐Chieh Lin, Kathryn Razavi‐Shearer, Wai‐Kay Seto, Grace L. ‐H. Wong, Vincent
  Alimentary Pharmacology & Therapeutics.2020; 51(8): 801.     CrossRef
• Association of grip strength with non-alcoholic fatty liver disease: investigation of the roles of insulin resistance and inflammation as mediators
  Seung Ha Park, Dong Joon Kim, Lindsay D. Plank
  European Journal of Clinical Nutrition.2020; 74(10): 1401.     CrossRef
• Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis
  Stergios A. Polyzos, Eun Seok Kang, Chrysoula Boutari, Eun-Jung Rhee, Christos S. Mantzoros
  Metabolism.2020; 111: 154203.     CrossRef
• Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk
  Eugene Han, Yong-ho Lee, Young Dae Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Kwang-Hyub Han, Hyo Suk Nam, Ji Hoe Heo, Seung Up Kim
  American Journal of Gastroenterology.2020; 115(4): 584.     CrossRef
• Neddylation of sterol regulatory element-binding protein 1c is a potential therapeutic target for nonalcoholic fatty liver treatment
  Uk-Il Ju, Do-Won Jeong, Jieun Seo, Jun Bum Park, Jong-Wan Park, Kyung-Suk Suh, Jae Bum Kim, Yang-Sook Chun
  Cell Death & Disease.2020;[Epub]     CrossRef
• Nonalcoholic Fatty Liver Disease Is Associated with Benign Prostate Hyperplasia
  Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Boram Park, Seong Joon An, Joo Sung Kim
  Journal of Korean Medical Science.2020;[Epub]     CrossRef
• Dose–response association between physical activity and non-alcoholic fatty liver disease: a case–control study in a Chinese population
  YangFan Li, Fei He, Yun He, XinTing Pan, YunLi Wu, ZhiJian Hu, Xu Lin, Xian-E Peng, ShangHua Xu
  BMJ Open.2020; 9(3): e026854.     CrossRef
• Treatment of Non-Alcoholic Steatosis: Preclinical Study of a New Nutraceutical Multitarget Formulation
  Laura Micheli, Alessandra Pacini, Lorenzo Di Cesare Mannelli, Elena Trallori, Roberta D’Ambrosio, Carlo Bianchini, Pietro Lampertico, Carla Ghelardini
  Nutrients.2020; 12(6): 1819.     CrossRef
• The increased amount of coffee consumption lowers the incidence of fatty liver disease in Korean men
  Hye-Kyung Chung, Ji Sun Nam, Mi-Yeon Lee, Yong-Bum Kim, Yu-Sam Won, Won-Jun Song, Young-Hwan Kim, Chul Woo Ahn, Ki-Chul Sung
  Nutrition, Metabolism and Cardiovascular Diseases.2020; 30(10): 1653.     CrossRef
• Risk of hepatocellular carcinoma in individuals without traditional risk factors: development and validation of a novel risk score
  Dong Hyun Sinn, Danbee Kang, Soo Jin Cho, Seung Woon Paik, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
  International Journal of Epidemiology.2020; 49(5): 1562.     CrossRef
• History of Nonalcoholic Fatty Liver Disease
  Amedeo Lonardo, Simona Leoni, Khalid A. Alswat, Yasser Fouad
  International Journal of Molecular Sciences.2020; 21(16): 5888.     CrossRef
• Dietary patterns are associated with the prevalence of nonalcoholic fatty liver disease in Korean adults
  Goh Eun Chung, Jiyoung Youn, Young Sun Kim, Jung Eun Lee, Sun Young Yang, Joo Hyun Lim, Ji Hyun Song, Eun Young Doo, Joo Sung Kim
  Nutrition.2019; 62: 32.     CrossRef
• Non-alcoholic fatty liver disease and cerebral small vessel disease in Korean cognitively normal individuals
  Hyemin Jang, Danbee Kang, Yoosoo Chang, Yeshin Kim, Jin San Lee, Ko Woon Kim, Young Kyoung Jang, Hee Jin Kim, Duk L. Na, Hee Young Shin, Mira Kang, Eliseo Guallar, Juhee Cho, Sang Won Seo
  Scientific Reports.2019;[Epub]     CrossRef
• Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease
  Min Cheol Kim, Jung Gil Park, Byung Ik Jang, Heon Ju Lee, Won Kee Lee
  Medicine.2019; 98(6): e14139.     CrossRef
• Association of low skeletal muscle mass with advanced liver fibrosis in patients with non‐alcoholic fatty liver disease
  Min Kyu Kang, Jung Gil Park, Heon Ju Lee, Min Cheol Kim
  Journal of Gastroenterology and Hepatology.2019; 34(9): 1633.     CrossRef
• What are the main areas of focus to prevent or treat non‐alcoholic fatty liver disease?
  Asieh Mansour, Azita Hekmatdoost, Parvin Mirmiran
  Journal of Digestive Diseases.2019; 20(6): 271.     CrossRef
• Favorable impact of non‐alcoholic fatty liver disease on the cerebral white matter hyperintensity in a neurologically healthy population
  S.‐M. Jeong, H. Kwon, S. Park, S. J. Yu, H.‐Y. Jeong, K.‐W. Nam, H.‐M. Kwon, J.‐H. Park
  European Journal of Neurology.2019; 26(12): 1471.     CrossRef
• Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR/LXRs-dependent manner
  Xin Han, Zhen-Yu Cui, Jian Song, Hui-Qing Piao, Li-Hua Lian, Li-Shuang Hou, Ge Wang, Shuang Zheng, Xiu-Xiu Dong, Ji-Xing Nan, Yan-Ling Wu
  Chemico-Biological Interactions.2019; 311: 108794.     CrossRef
• Association between non-alcoholic fatty liver disease and cancer incidence rate
  Gi-Ae Kim, Han Chu Lee, Jaewon Choe, Min-Ju Kim, Min Jung Lee, Hye-Sook Chang, In Young Bae, Hong-Kyu Kim, Jihyun An, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim
  Journal of Hepatology.2018; 68(1): 140.     CrossRef
• Effect of longitudinal changes of body fat on the incidence and regression of nonalcoholic fatty liver disease
  Donghee Kim, Goh Eun Chung, Min-Sun Kwak, Yoon Jun Kim, Jung-Hwan Yoon
  Digestive and Liver Disease.2018; 50(4): 389.     CrossRef
• Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction
  Goh Eun Chung, Jeong-Hoon Lee, Heesun Lee, Min Kyung Kim, Jeong Yoon Yim, Su-Yeon Choi, Yoon Jun Kim, Jung-Hwan Yoon, Donghee Kim
  Atherosclerosis.2018; 272: 137.     CrossRef
• Genetic Polymorphisms of PNPLA3 and SAMM50 Are Associated with Nonalcoholic Fatty Liver Disease in a Korean Population
  Goh Eun Chung, Young Lee, Jeong Yoon Yim, Eun Kyung Choe, Min-Sun Kwak, Jong In Yang, Boram Park, Jong-Eun Lee, Jeong A Kim, Joo Sung Kim
  Gut and Liver.2018; 12(3): 316.     CrossRef
• Management of Patients with Nonalcoholic Fatty Liver Disease with Lifestyle Modification
  Byung-Wan Lee
  The Journal of Korean Diabetes.2018; 19(2): 82.     CrossRef
• Glucose-Lowering Agents in the Management of Nonalcoholic Fatty Liver Disease
  Hyekyung Yang, Cheol-Young Park
  The Journal of Korean Diabetes.2018; 19(2): 88.     CrossRef
• Epigenetics: An emerging field in the pathogenesis of nonalcoholic fatty liver disease
  Nissar U. Ashraf, Mohammad Altaf
  Mutation Research/Reviews in Mutation Research.2018; 778: 1.     CrossRef
• Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States
  Seung Joo Kang, Hwa Jung Kim, Donghee Kim, Aijaz Ahmed, Silvia C. Sookoian
  PLOS ONE.2018; 13(8): e0202325.     CrossRef
• Associations between hemoglobin concentrations and the development of incidental metabolic syndrome or nonalcoholic fatty liver disease
  Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Su Jin Chung, Sun Young Yang, Joo Sung Kim
  Digestive and Liver Disease.2017; 49(1): 57.     CrossRef
• Epigenetics in non-alcoholic fatty liver disease
  Jooho Lee, Yuri Kim, Simonetta Friso, Sang-Woon Choi
  Molecular Aspects of Medicine.2017; 54: 78.     CrossRef
• Non‐alcoholic fatty liver diseases and risk of colorectal neoplasia
  J. S. Ahn, D. H. Sinn, Y. W. Min, S. N. Hong, H. S. Kim, S.‐H. Jung, S. Gu, P.‐L. Rhee, S. W. Paik, H. J. Son, G.‐Y. Gwak
  Alimentary Pharmacology & Therapeutics.2017; 45(2): 345.     CrossRef
• The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease
  Min‐Sun Kwak, Donghee Kim, Goh Eun Chung, Won Kim, Joo Sung Kim
  Liver International.2017; 37(6): 919.     CrossRef
• Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study
  Dong Hyun Sinn, Danbee Kang, Yoosoo Chang, Seungho Ryu, Seonhye Gu, Hyunkyoung Kim, Donghyeong Seong, Soo Jin Cho, Byoung-Kee Yi, Hyung-Doo Park, Seung Woon Paik, Young Bin Song, Mariana Lazo, Joao A C Lima, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
  Gut.2017; 66(2): 323.     CrossRef
• Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma
  Jee San Lee, Jeong Eun Yoo, Haeryoung Kim, Hyungjin Rhee, Myoung Ju Koh, Ji Hae Nahm, Jin Sub Choi, Kee-Ho Lee, Young Nyun Park, Olorunseun Ogunwobi
  PLOS ONE.2017; 12(3): e0171922.     CrossRef
• A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease
  Tae Jun Kim, Dong Hyun Sinn, Yang Won Min, Hee Jung Son, Jae J. Kim, Yoosoo Chang, Sun-Young Baek, Soo Hyun Ahn, Hyuk Lee, Seungho Ryu
  Journal of Gastroenterology.2017; 52(11): 1201.     CrossRef
• Radiologic Evaluation of Non-Alcoholic Fatty Liver Disease in Diabetic Patient
  Kwang Joon Kim, Seung Up Kim, Yong Eun Chung, Chang Oh Kim
  The Journal of Korean Diabetes.2017; 18(2): 88.     CrossRef
• Non-alcoholic Fatty Liver Disease: A Clinical Update
  Joseph M Pappachan, Shithu Babu, Babu Krishnan, Nishal C Ravindran
  Journal of Clinical and Translational Hepatology.2017; XX(XX): XX.     CrossRef
• Diagnosis of Non-Alcoholic Fatty Liver Disease Based on Clinical and Laboratory Data
  Yong-ho Lee
  The Journal of Korean Diabetes.2017; 18(2): 102.     CrossRef
• Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study
  Dong Hyun Sinn, Danbee Kang, Hye Ryoun Jang, Seonhye Gu, Soo Jin Cho, Seung Woon Paik, Seungho Ryu, Yoosoo Chang, Mariana Lazo, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
  Journal of Hepatology.2017; 67(6): 1274.     CrossRef
• Effects of Kamichunggantang on Lipoapoptosis and inflammation of NAFLD in db/db mice
  Soo young Kwon, Kang-Hoon Kim, Yumi Kim, In-Seung Lee, Ji Young Park, Hyeon-Soo jeong, Jang-Hoon Lee, Hyeung-Jin Jang
  Oriental Pharmacy and Experimental Medicine.2017; 17(4): 365.     CrossRef
• Pharmacotherapy of nonalcoholic steatohepatitis: Reflections on the existing evidence
  Jie Ting Tang, Yi Min Mao
  Journal of Digestive Diseases.2017; 18(11): 607.     CrossRef
• Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease
  Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang Joon Kim, Kwang-Hyub Han
  Digestive Diseases and Sciences.2017; 62(8): 2150.     CrossRef
• Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men
  Hae Jin Yang, Sang Goon Shim, Bong Oh Ma, Ji Yeong Kwak
  European Journal of Gastroenterology & Hepatology.2016; 28(3): 338.     CrossRef
• Discordance between conventional ultrasonography and ElastPQ for assessing hepatic fibrosis in chronic hepatitis B: frequency and independent factors
  Mi Sung Kim, Byung Ik Kim, Heon-Ju Kwon, Hae Won Park, Hee-Jin Park, Ki Bae Bang, Hyun Pyo Hong, Myung Ho Rho
  Journal of Medical Ultrasonics.2016; 43(2): 201.     CrossRef
• Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis
  Dong Hyun Sinn, Soo Jin Cho, Geum-Youn Gwak, Juhee Cho, Seonhye Gu, Donghyeong Seong, Danbee Kang, Hyunkyoung Kim, Byoung-Kee Yi, Seung Woon Paik
  Medicine.2016; 95(3): e2578.     CrossRef
• Anti-inflammatory and antifatigue effect of Korean Red Ginseng in patients with nonalcoholic fatty liver disease
  Meegun Hong, Yoon Hyeong Lee, Seungwoo Kim, Ki Tae Suk, Chang Seok Bang, Jai Hoon Yoon, Gwang Ho Baik, Dong Joon Kim, Myong Jo Kim
  Journal of Ginseng Research.2016; 40(3): 203.     CrossRef
• Can Pharmacologic Therapy Induce Histologic Improvement in Non-alcoholic Steatohepatitis?
  Nae-Yun Heo
  The Korean Journal of Gastroenterology.2016; 67(5): 286.     CrossRef
• Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis
  Dong Hyun Sinn, Soo Jin Cho, Seonhye Gu, Donghyeong Seong, Danbee Kang, Hyunkyoung Kim, Byoung-Kee Yi, Seung Woon Paik, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
  Gastroenterology.2016; 151(3): 481.     CrossRef
• Relationship between 25-Hydroxyvitamin D Levels and Liver Fibrosis as Assessed by Transient Elastography in Patients with Chronic Liver Disease
  Bong Jin Ko, Young Seok Kim, Sang Gyune Kim, Jung Hwan Park, Sae Hwan Lee, Soung Won Jeong, Jae Young Jang, Hong Soo Kim, Boo Sung Kim, Sun Mi Kim, Young Don Kim, Gab Jin Cheon, Bo Ra Lee
  Gut and Liver.2016; 10(5): 818.     CrossRef
• Associations between White Blood Cell Count and the Development of Incidental Nonalcoholic Fatty Liver Disease
  Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Su Jin Chung, Sun Young Yang, Joo Sung Kim
  Gastroenterology Research and Practice.2016; 2016: 1.     CrossRef
• Clinical guidelines of non-alcoholic fatty liver disease: A systematic review
  Jin-Zhou Zhu, Kelseanna Hollis-Hansen, Xing-Yong Wan, Su-Juan Fei, Xun-Lei Pang, Fan-Dong Meng, Chao-Hui Yu, You-Ming Li
  World Journal of Gastroenterology.2016; 22(36): 8226.     CrossRef
• Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study
  Gi Hyun Kim, Jung Wha Chung, Jong Ho Lee, Kyeong Sam Ok, Eun Sun Jang, Jaihwan Kim, Cheol Min Shin, Young Soo Park, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee, Jin-Wook Kim
  Clinical and Molecular Hepatology.2015; 21(4): 379.     CrossRef
• The Influence of Metabolic Factors for Nonalcoholic Fatty Liver Disease in Women
  Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Seon Hee Lim, Jong In Yang, Young Sun Kim, Sun Young Yang, Min-Sun Kwak, Joo Sung Kim, Sang-Heon Cho
  BioMed Research International.2015; 2015: 1.     CrossRef
• Hepatic fat, not visceral fat, is associated with gallbladder polyps: A study of 2643 healthy subjects
  Seon Hee Lim, Donghee Kim, Jin Hwa Kang, Ji Hyun Song, Sun Young Yang, Jeong Yun Yim, Su Jin Chung, Joo Sung Kim, Sang‐Heon Cho
  Journal of Gastroenterology and Hepatology.2015; 30(4): 767.     CrossRef
• Visceral Adipose Tissue Area as an Independent Risk Factor for Elevated Liver Enzyme in Nonalcoholic Fatty Liver Disease
  Goh Eun Chung, Donghee Kim, Min Sun Kwark, Won Kim, Jeong Yoon Yim, Yoon Jun Kim, Jung-Hwan Yoon
  Medicine.2015; 94(9): e573.     CrossRef
• Nonalcoholic Fatty Liver Disease as a Risk Factor of Arterial Stiffness Measured by the Cardioankle Vascular Index
  Goh Eun Chung, Su-Yeon Choi, Donghee Kim, Min-Sun Kwak, Hyo Eun Park, Min-Kyung Kim, Jeong Yoon Yim
  Medicine.2015; 94(12): e654.     CrossRef
• Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
  Su Jong Yu, Won Kim, Donghee Kim, Jung-Hwan Yoon, Kyoungbun Lee, Jung Ho Kim, Eun Ju Cho, Jeong-Hoon Lee, Hwi Young Kim, Yoon Jun Kim, Chung Yong Kim
  Medicine.2015; 94(48): e2159.     CrossRef
• Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance
  Min‐Sun Kwak, Donghee Kim, Goh Eun Chung, Won Kim, Yoon Jun Kim, Jung‐Hwan Yoon
  Liver International.2015; 35(3): 944.     CrossRef
• Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population
  Min-Sun Kwak
  World Journal of Gastroenterology.2015; 21(20): 6287.     CrossRef
• Management of Non-alcoholic Fatty Liver Disease
  Jaechan Leem, Eun Hee Koh
  The Journal of Korean Diabetes.2014; 15(2): 93.     CrossRef
• Epigenetic Mechanisms Underlying the Link between Non-Alcoholic Fatty Liver Diseases and Nutrition
  Joo Lee, Simonetta Friso, Sang-Woon Choi
  Nutrients.2014; 6(8): 3303.     CrossRef
• The Diagnosis of Nonalcoholic Fatty Liver Disease
  Moon Young Kim
  Korean Journal of Medicine.2014; 86(4): 405.     CrossRef
• Clinical Correlation between Serum Cytokeratin-18 and Metabolic Parameters in Patients with Sonographic Non-alcoholic Fatty Liver Disease
  Dong Shin Kwak, Dae Won Jun, Yong Kyun Cho, Seung Min Lee, Se Hwan Lee, In Sub Jung, Sung Won Lee, Jae Keun Park, JungHoon Lee, Eun Young Lee, Min Rho, Kang Lok Lee, Jun Kwon Ko, Soon-Eung Park
  The Korean Journal of Gastroenterology.2014; 64(4): 206.     CrossRef
• Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease
  Sang Hoon Park
  Korean Journal of Medicine.2014; 86(4): 425.     CrossRef
• Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: The role of interdisciplinary therapy
  Priscila L. Sanches, Aline de Piano, Raquel M.S. Campos, June Carnier, Marco T. de Mello, Natália Elias, Francisco A.H. Fonseca, Deborah C.L. Masquio, Patrícia L. da Silva, Flavia C. Corgosinho, Lian Tock, Lila M. Oyama, Sergio Tufik, Ana R. Dâmaso
  Journal of Clinical Lipidology.2014; 8(3): 265.     CrossRef
• Comparison on the Efficacy and Safety of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycholic Acid in Patients with Abnormal Alanine Aminotransferase: Multicenter, Double-blinded, Randomized, Active-controlled Clinical Trial
  Sae Hwan Lee, Gab Jin Cheon, Hong Soo Kim, Young Don Kim, Sang Gyune Kim, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim
  The Korean Journal of Gastroenterology.2014; 64(1): 31.     CrossRef
• Nonalcoholic Fatty Liver Disease: Lifestyle Modification
  Ki Deok Yoo, Dae Won Jun
  Korean Journal of Medicine.2014; 86(4): 416.     CrossRef